<?xml version="1.0" encoding="UTF-8"?>
<OAI-PMH xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2024-05-03T01:46:58Z</responseDate>
  <request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:8528465" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:pubmedcentral.nih.gov:8528465</identifier>
        <datestamp>2021-10-27</datestamp>
        <setSpec>ancltransneuro</setSpec>
        <setSpec>pmc-open</setSpec>
      </header>
      <metadata>
        <article xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.3/ https://jats.nlm.nih.gov/archiving/1.3/xsd/JATS-archivearticle1-3.xsd" dtd-version="1.3" id="acn351437" xml:lang="en" article-type="research-article">
          <processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
            <restricted-by>pmc</restricted-by>
          </processing-meta>
          <front>
            <journal-meta>
              <journal-id journal-id-type="nlm-ta">Ann Clin Transl Neurol</journal-id>
              <journal-id journal-id-type="iso-abbrev">Ann Clin Transl Neurol</journal-id>
              <journal-id journal-id-type="doi">10.1002/(ISSN)2328-9503</journal-id>
              <journal-id journal-id-type="publisher-id">ACN3</journal-id>
              <journal-title-group>
                <journal-title>Annals of Clinical and Translational Neurology</journal-title>
              </journal-title-group>
              <issn pub-type="epub">2328-9503</issn>
              <publisher>
                <publisher-name>John Wiley and Sons Inc.</publisher-name>
                <publisher-loc>Hoboken</publisher-loc>
              </publisher>
            </journal-meta>
            <article-meta>
              <article-id pub-id-type="accession">PMC8528465</article-id>
              <article-id pub-id-type="pmcid">PMC8528465</article-id>
              <article-id pub-id-type="pmc-uid">8528465</article-id>
              <article-id pub-id-type="pmid">34562313</article-id>
              <article-id pub-id-type="pmid">34562313</article-id>
              <article-id pub-id-type="doi">10.1002/acn3.51437</article-id>
              <article-id pub-id-type="publisher-id">ACN351437</article-id>
              <article-categories>
                <subj-group subj-group-type="overline">
                  <subject>Research Article</subject>
                </subj-group>
                <subj-group subj-group-type="heading">
                  <subject>Research Article</subject>
                </subj-group>
              </article-categories>
              <title-group>
                <article-title>Clinical trial of raltegravir, an integrase inhibitor, in HAM/TSP</article-title>
                <alt-title alt-title-type="right-running-head">Clinical Trial of Raltegravir in HAM/TSP</alt-title>
                <alt-title alt-title-type="left-running-head">Y. Enose‐Akahata <italic toggle="no">et al</italic>.</alt-title>
              </title-group>
              <contrib-group>
                <contrib id="acn351437-cr-0001" contrib-type="author">
                  <name>
                    <surname>Enose‐Akahata</surname>
                    <given-names>Yoshimi</given-names>
                  </name>
                  <xref rid="acn351437-aff-0001" ref-type="aff">
                    <sup>1</sup>
                  </xref>
                </contrib>
                <contrib id="acn351437-cr-0002" contrib-type="author">
                  <name>
                    <surname>Billioux</surname>
                    <given-names>Bridgette Jeanne</given-names>
                  </name>
                  <xref rid="acn351437-aff-0001" ref-type="aff">
                    <sup>1</sup>
                  </xref>
                </contrib>
                <contrib id="acn351437-cr-0003" contrib-type="author">
                  <name>
                    <surname>Azodi</surname>
                    <given-names>Shila</given-names>
                  </name>
                  <xref rid="acn351437-aff-0001" ref-type="aff">
                    <sup>1</sup>
                  </xref>
                </contrib>
                <contrib id="acn351437-cr-0004" contrib-type="author">
                  <name>
                    <surname>Dwyer</surname>
                    <given-names>Jennifer</given-names>
                  </name>
                  <xref rid="acn351437-aff-0002" ref-type="aff">
                    <sup>2</sup>
                  </xref>
                </contrib>
                <contrib id="acn351437-cr-0005" contrib-type="author">
                  <name>
                    <surname>Vellucci</surname>
                    <given-names>Ashley</given-names>
                  </name>
                  <xref rid="acn351437-aff-0001" ref-type="aff">
                    <sup>1</sup>
                  </xref>
                </contrib>
                <contrib id="acn351437-cr-0006" contrib-type="author">
                  <name>
                    <surname>Ngouth</surname>
                    <given-names>Nyater</given-names>
                  </name>
                  <xref rid="acn351437-aff-0001" ref-type="aff">
                    <sup>1</sup>
                  </xref>
                </contrib>
                <contrib id="acn351437-cr-0007" contrib-type="author">
                  <name>
                    <surname>Nozuma</surname>
                    <given-names>Satoshi</given-names>
                  </name>
                  <xref rid="acn351437-aff-0001" ref-type="aff">
                    <sup>1</sup>
                  </xref>
                </contrib>
                <contrib id="acn351437-cr-0008" contrib-type="author">
                  <name>
                    <surname>Massoud</surname>
                    <given-names>Raya</given-names>
                  </name>
                  <xref rid="acn351437-aff-0001" ref-type="aff">
                    <sup>1</sup>
                  </xref>
                </contrib>
                <contrib id="acn351437-cr-0009" contrib-type="author">
                  <name>
                    <surname>Cortese</surname>
                    <given-names>Irene</given-names>
                  </name>
                  <xref rid="acn351437-aff-0002" ref-type="aff">
                    <sup>2</sup>
                  </xref>
                </contrib>
                <contrib id="acn351437-cr-0010" contrib-type="author">
                  <name>
                    <surname>Ohayon</surname>
                    <given-names>Joan</given-names>
                  </name>
                  <xref rid="acn351437-aff-0002" ref-type="aff">
                    <sup>2</sup>
                  </xref>
                  <xref rid="acn351437-note-0001" ref-type="author-notes">
                    <sup>*</sup>
                  </xref>
                </contrib>
                <contrib id="acn351437-cr-0011" contrib-type="author" corresp="yes">
                  <name>
                    <surname>Jacobson</surname>
                    <given-names>Steven</given-names>
                  </name>
                  <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-3127-1287</contrib-id>
                  <xref rid="acn351437-aff-0001" ref-type="aff">
                    <sup>1</sup>
                  </xref>
                  <xref rid="acn351437-note-0001" ref-type="author-notes">
                    <sup>*</sup>
                  </xref>
                  <address>
                    <email>jacobsons@ninds.nih.gov</email>
                  </address>
                </contrib>
              </contrib-group>
              <aff id="acn351437-aff-0001">
                <label>
                  <sup>1</sup>
                </label>
                <named-content content-type="organisation-division">Viral Immunology Section, National Institute of Neurological Disorders and Stroke</named-content>
                <institution>National Institutes of Health</institution>
                <city>Bethesda</city>
                <named-content content-type="country-part">Maryland</named-content>
                <postal-code>20892</postal-code>
                <country country="US">USA</country>
              </aff>
              <aff id="acn351437-aff-0002">
                <label>
                  <sup>2</sup>
                </label>
                <named-content content-type="organisation-division">Neuroimmunology Clinic, National Institute of Neurological Disorders and Stroke</named-content>
                <institution>National Institutes of Health</institution>
                <city>Bethesda</city>
                <named-content content-type="country-part">Maryland</named-content>
                <postal-code>20892</postal-code>
                <country country="US">USA</country>
              </aff>
              <author-notes>
                <corresp id="correspondenceTo"><label>*</label><bold>Correspondence</bold><break/>
Steven Jacobson, Viral Immunology Section, NINDS, NIH, 10 Center Dr, Building 10, Room 5C103, Bethesda, MD 20892. Tel: +1 301 496 0519; Fax: +1 301 402 0373; E‐mail: <email>jacobsons@ninds.nih.gov</email>
<break/>
</corresp>
                <fn id="acn351437-note-0001">
                  <label>*</label>
                  <p>Shared senior authors.</p>
                </fn>
              </author-notes>
              <pub-date pub-type="epub">
                <day>25</day>
                <month>9</month>
                <year>2021</year>
              </pub-date>
              <pub-date pub-type="collection">
                <month>10</month>
                <year>2021</year>
              </pub-date>
              <volume>8</volume>
              <issue seq="50">10</issue>
              <issue-id pub-id-type="doi">10.1002/acn3.v8.10</issue-id>
              <fpage>1970</fpage>
              <lpage>1985</lpage>
              <history>
                <date date-type="received">
                  <day>19</day>
                  <month>6</month>
                  <year>2021</year>
                </date>
                <date date-type="accepted">
                  <day>09</day>
                  <month>7</month>
                  <year>2021</year>
                </date>
              </history>
              <permissions>
                <!--&#x000a9; 2021 American Neurological Association-->
                <copyright-statement content-type="article-copyright">© 2021 Published 2021. This article is a U.S. Government work and is in the public domain in the USA. Annals of Clinical and Translational Neurology published by Wiley Periodicals LLC on behalf of American Neurological Association.</copyright-statement>
                <license>
                  <ali:license_ref specific-use="textmining" content-type="ccbyncndlicense">https://creativecommons.org/licenses/by-nc-nd/4.0/</ali:license_ref>
                  <license-p>This is an open access article under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">http://creativecommons.org/licenses/by-nc-nd/4.0/</ext-link> License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.</license-p>
                </license>
              </permissions>
              <self-uri content-type="pdf" xlink:href="file:ACN3-8-1970.pdf"/>
              <abstract id="acn351437-abs-0001">
                <title>Abstract</title>
                <sec id="acn351437-sec-0001">
                  <title>Objective</title>
                  <p>Human T‐cell lymphotropic virus 1 (HTLV‐1)‐associated myelopathy/tropical spastic paraparesis (HAM/TSP) is a chronic, progressive myelopathy. A high proviral load (PVL) is one of the main risk factors for HAM/TSP. Recently, it was shown that raltegravir could inhibit cell‐free and cell‐to‐cell transmission of HTLV‐1 in vitro. Given the substantial clinical experience in human immunodeficiency virus infection and its excellent safety profile, this agent may be an attractive therapeutic option for HAM/TSP patients.</p>
                </sec>
                <sec id="acn351437-sec-0002">
                  <title>Methods</title>
                  <p>Sixteen subjects with HAM/TSP received raltegravir 400 mg orally twice daily in an initial 6‐month treatment phase, followed by a 9‐month post‐treatment phase. HTLV‐1 PVLs were assessed using droplet digital PCR from the PBMCs every 3 months, and from the CSF at baseline, month 6, and month 15. We also evaluated the ability of raltegravir to regulate abnormal immune responses in HAM/TSP patients.</p>
                </sec>
                <sec id="acn351437-sec-0003">
                  <title>Results</title>
                  <p>While a downward trend was observed in PBMC and/or CSF PVLs of some patients, raltegravir overall did not have any impact on the PVL in this HAM/TSP patient cohort. Clinically, all patients’ neurological scores and objective measurements remained relatively stable, with some expected variability. Immunologic studies showed alterations in the immune profiles of a subset of patients including decreased CD4<sup>+</sup>CD25<sup>+</sup> T cells and spontaneous lymphoproliferation.</p>
                </sec>
                <sec id="acn351437-sec-0004">
                  <title>Interpretation</title>
                  <p>Raltegravir was generally well tolerated in this HAM/TSP patient cohort. A subset of patients exhibited a mild decrease in PVL as well as variations in their immune profiles after taking raltegravir. These findings suggest that raltegravir may be a therapeutic option in select HAM/TSP patients.</p>
                </sec>
                <sec id="acn351437-sec-0005">
                  <title>Clinical Trial Registration Number</title>
                  <p>NCT01867320.</p>
                </sec>
              </abstract>
              <funding-group>
                <award-group id="funding-0001">
                  <funding-source>
                    <institution-wrap>
                      <institution>NINDS
</institution>
                      <institution-id institution-id-type="doi">10.13039/100000065</institution-id>
                    </institution-wrap>
                  </funding-source>
                </award-group>
                <award-group id="funding-0002">
                  <funding-source>
                    <institution-wrap>
                      <institution>NIH
</institution>
                      <institution-id institution-id-type="doi">10.13039/100000002</institution-id>
                    </institution-wrap>
                  </funding-source>
                </award-group>
                <funding-statement>This work was funded by <funding-source><institution-wrap><institution>NINDS
</institution><institution-id institution-id-type="doi">10.13039/100000065</institution-id></institution-wrap></funding-source>; <funding-source><institution-wrap><institution>NIH
</institution><institution-id institution-id-type="doi">10.13039/100000002</institution-id></institution-wrap></funding-source>.</funding-statement>
              </funding-group>
              <counts>
                <fig-count count="5"/>
                <table-count count="3"/>
                <page-count count="16"/>
                <word-count count="9890"/>
              </counts>
              <custom-meta-group>
                <custom-meta>
                  <meta-name>source-schema-version-number</meta-name>
                  <meta-value>2.0</meta-value>
                </custom-meta>
                <custom-meta>
                  <meta-name>cover-date</meta-name>
                  <meta-value>October 2021</meta-value>
                </custom-meta>
                <custom-meta>
                  <meta-name>details-of-publishers-convertor</meta-name>
                  <meta-value>Converter:WILEY_ML3GV2_TO_JATSPMC version:6.0.8 mode:remove_FC converted:20.10.2021</meta-value>
                </custom-meta>
              </custom-meta-group>
            </article-meta>
            <notes>
              <fn-group id="acn351437-ntgp-0001">
                <fn fn-type="funding" id="acn351437-note-0002">
                  <p>
                    <bold>Funding Information</bold>
                  </p>
                  <p>This research was supported by the Intramural Research Program of the NINDS, NIH. The support of the NIH inpatient and outpatient neurology staff is acknowledged.</p>
                </fn>
              </fn-group>
            </notes>
          </front>
          <body id="acn351437-body-0001">
            <sec id="acn351437-sec-0006">
              <title>Introduction</title>
              <p>Human T‐cell lymphotropic virus 1 (HTLV‐1) is a human retrovirus and causes persistent infection in humans. HTLV‐1‐associated myelopathy/tropical spastic paraparesis (HAM/TSP) is a chronic, progressive, neurological disease, which is clinically characterized by progressive lower extremity weakness, spasticity, and bladder/bowel sphincter dysfunction.<xref rid="acn351437-bib-0001" ref-type="bibr"><sup>1</sup></xref>, <xref rid="acn351437-bib-0002" ref-type="bibr"><sup>2</sup></xref> HAM/TSP is associated with perivascular inflammatory T cell infiltrates in the brain and spinal cord.<xref rid="acn351437-bib-0003" ref-type="bibr"><sup>3</sup></xref> A higher HTLV‐1 proviral load (PVL) and high level of HTLV‐1‐specific antibodies are also detected in peripheral blood and cerebrospinal fluid (CSF) of HAM/TSP patients.<xref rid="acn351437-bib-0001" ref-type="bibr"><sup>1</sup></xref>, <xref rid="acn351437-bib-0002" ref-type="bibr"><sup>2</sup></xref>, <xref rid="acn351437-bib-0004" ref-type="bibr"><sup>4</sup></xref> Thus, infiltration of inflammatory cells including HTLV‐1‐infected cells into the central nervous system associated with a chronically activated immune responses against HTLV‐1 have been suggested to underlie the pathogenesis of HAM/TSP. To date, no therapy has been shown to significantly modify the long‐term disability associated with HAM/TSP.</p>
              <p>An elevated HTLV‐1 PVL has been suggested to be the main risk factor for developing HAM/TSP in HTLV‐1‐infected subjects.<xref rid="acn351437-bib-0005" ref-type="bibr"><sup>5</sup></xref> Although HTLV‐1 PVL varies widely among HTLV‐1‐infected subjects and remains relatively stable within each subject, a higher HTLV‐1 PVL is frequently observed in the blood of HAM/TSP patients compared to asymptomatic carriers (ACs) and is particularly increased in the cells from CSF.<xref rid="acn351437-bib-0004" ref-type="bibr"><sup>4</sup></xref> Elevated PVL was correlated with increased HTLV‐1 <italic toggle="yes">tax</italic> mRNA expression and Tax‐specific CD8<sup>+</sup> T cells in HAM/TSP patients.<xref rid="acn351437-bib-0006" ref-type="bibr"><sup>6</sup></xref> The main reservoir of HTLV‐1, CD4<sup>+</sup>CD25 (IL‐2 receptor α chain)<sup>+</sup> T cells, were shown to express HTLV‐1 <italic toggle="yes">tax</italic> mRNA at significantly higher levels than in CD4<sup>+</sup>CD25<sup>−</sup> T cells and produce various cytokines including IFN‐γ.<xref rid="acn351437-bib-0007" ref-type="bibr"><sup>7</sup></xref>, <xref rid="acn351437-bib-0008" ref-type="bibr"><sup>8</sup></xref> It has also been reported that CD4<sup>+</sup>CD25<sup>+</sup> T cells were significantly higher in the CSF of HAM/TSP patients, compared to ACs and healthy controls, which was also significantly correlated with HTLV‐1 PVL and the presence of antibody secreting B cells in the CSF of HAM/TSP patients.<xref rid="acn351437-bib-0009" ref-type="bibr"><sup>9</sup></xref> Therefore, reduction in the HTLV‐1 PVL by use of antiretrovirals may prevent immune dysregulation in HAM/TSP patients thereby modulating or reducing progression and severity of disease.</p>
              <p>Raltegravir is the integrase inhibitor which, in combination with other antiretroviral medications, is used in both treatment‐naive and treatment‐experienced patients with human immunodeficiency virus 1 (HIV‐1).<xref rid="acn351437-bib-0010" ref-type="bibr"><sup>10</sup></xref> In HTLV‐1, it has been reported that raltegravir efficiently blocked cell‐to‐cell HTLV‐1 infection, integration, and immortalization in vitro.<xref rid="acn351437-bib-0011" ref-type="bibr"><sup>11</sup></xref>, <xref rid="acn351437-bib-0012" ref-type="bibr"><sup>12</sup></xref> A small case study reported that two HAM/TSP patients treated with raltegravir showed a transient decline of HTLV‐1 PVL in PBMCs.<xref rid="acn351437-bib-0013" ref-type="bibr"><sup>13</sup></xref> Given the substantial clinical experience with its use in HIV‐1 infection and its safety profile, raltegravir might be considered as a therapeutic option for HAM/TSP patients, either alone or in combination with other antiretroviral treatment.</p>
              <p>In this single‐center, single‐arm, open‐label pilot trial, 16 HAM/TSP patients received raltegravir at 400 mg orally twice daily in an initial 6‐month treatment phase, followed by an additional 9‐month post‐treatment phase. The goals of the study were to evaluate the safety and tolerability of raltegravir and the ability to reduce HTLV‐1 PVL and to regulate immune responses in HAM/TSP patients following treatment with raltegravir.</p>
            </sec>
            <sec sec-type="methods" id="acn351437-sec-0007">
              <title>Methods</title>
              <sec id="acn351437-sec-0008">
                <title>Patients and treatment plan</title>
                <p>Eighteen patients with clinically defined HAM/TSP by the WHO criteria were enrolled into the clinical trial of raltegravir in HAM/TSP (NCT01867320). The trial schema is summarized in Figure <xref rid="acn351437-fig-0001" ref-type="fig">1</xref>. The patients received raltegravir 400 mg orally twice daily in an initial 6‐month treatment phase, followed by a 9‐month post‐treatment phase. Patients were evaluated clinically at each study time point (baseline/month 0, month 3, month 6, month 9, and month 15), with full neurological evaluations and clinical measures [Expanded Disability Status Scale (EDSS),<xref rid="acn351437-bib-0014" ref-type="bibr"><sup>14</sup></xref> Scripps Neurologic Rating Scale (SNRS),<xref rid="acn351437-bib-0015" ref-type="bibr"><sup>15</sup></xref> Timed 25 Foot Walk,<xref rid="acn351437-bib-0016" ref-type="bibr"><sup>16</sup></xref> Insituto de Pesquisa Clinica Evandro Chagas scale (IPEC),<xref rid="acn351437-bib-0017" ref-type="bibr"><sup>17</sup></xref> Ambulation Index (AI),<xref rid="acn351437-bib-0018" ref-type="bibr"><sup>18</sup></xref> 9‐Hole Peg Test<xref rid="acn351437-bib-0019" ref-type="bibr"><sup>19</sup></xref>] performed at each clinic visit. Of the 18 patients, 2 patients withdrew prior to the end of the treatment period, 1 due to skin reaction (possibly related to treatment) and 1 due to inability to travel for study visits (not related to treatment), and therefore both patients were not included in the final trial analysis. In addition, 27 healthy volunteers (NINDS protocol 13‐N‐0149) and 13 HAM/TSP patients (NINDS protocol 98‐N‐0047) were included for comparison of the immunological markers and coefficient of variation of the longitudinal HTLV‐1 PVL, respectively. Blood samples were taken at each study visit; PBMCs were isolated by Ficoll‐Hypaque (Lonza) centrifugation and cryopreserved in liquid nitrogen until use. CSF was obtained by lumbar puncture at baseline, month 6, and month 15 time points of the trial; the CSF cells were collected within an hour by centrifugation of CSF samples and stored in −80 °C freezer until use or freshly used for flow cytometric analysis. The study protocol (13‐N‐0135) was reviewed and approved by the National Institute of Neurological Disorders and Stroke Institutional Review Board. Prior to study inclusion, written informed consent was obtained from all the participants in accordance with the Declaration of Helsinki. Details on this clinical trial are recorded at clinicaltrials.gov (NCT01867320).</p>
                <fig position="float" fig-type="Figure" id="acn351437-fig-0001">
                  <label>Figure 1</label>
                  <caption>
                    <p>Schema of clinical trial of raltegravir for HAM/TSP patients.</p>
                  </caption>
                  <graphic xlink:href="ACN3-8-1970-g004" position="anchor" id="jats-graphic-1"/>
                </fig>
              </sec>
              <sec id="acn351437-sec-0009">
                <title>HTLV‐1 PVL</title>
                <p>HTLV‐1 PVL was measured using droplet digital PCR (ddPCR; Bio‐Rad) as previously described.<xref rid="acn351437-bib-0020" ref-type="bibr"><sup>20</sup></xref> DNA was extracted from the PBMC and CSF cell pellets using a DNeasy Blood and Tissue kit (Qiagen) according to the manufacturer’s instructions. Primers and probes specific for HTLV‐1 <italic toggle="yes">tax</italic> gene and human ribonuclease P protein subunit 30 (<italic toggle="yes">RPP30</italic>) was used. All samples were tested in duplicate, and PVL is reported as the average of the two measurements.</p>
              </sec>
              <sec id="acn351437-sec-0010">
                <title>HTLV‐1 tax/HBZ mRNA expression</title>
                <p>HTLV‐1 <italic toggle="yes">tax</italic> and <italic toggle="yes">HBZ</italic> mRNA was measured using ddPCR (Bio‐Rad) as previously described.<xref rid="acn351437-bib-0021" ref-type="bibr"><sup>21</sup></xref> RNA was extracted from fresh‐frozen PBMCs or cultured PBMCs for 20 h using a RNAeasy plus mini kit (Qiagen) and cDNA was synthesized from extracted RNA using a high capacity cDNA reverse transcriptase kit (Applied Biosystems). The primers and probes specific for HTLV‐1 <italic toggle="yes">tax</italic> and <italic toggle="yes">HBZ</italic> and hypoxanthine phosphoribosyl transferase (<italic toggle="yes">HPRT</italic>) were used. All samples were tested in duplicate, and normalized values of HTLV‐1 <italic toggle="yes">tax</italic> mRNA or <italic toggle="yes">HBZ</italic> mRNA to <italic toggle="yes">HPRT</italic> mRNA are reported as the average of the two measurements.</p>
              </sec>
              <sec id="acn351437-sec-0011">
                <title>Flow cytometry</title>
                <p>For analysis of peripheral blood lymphocyte and CSF lymphocyte populations, EDTA‐treated whole blood or CSF cells were stained with CD3, CD4, CD8, CD14, CD16, CD19, CD25, CD27, CD45, CD45RA, CD56, CD122, CXCR5, IgD, HLA‐DR (all from BD Biosciences), and FoxP3 (eBiosciences), as previously described.<xref rid="acn351437-bib-0009" ref-type="bibr"><sup>9</sup></xref>
</p>
                <p>For detections of HTLV‐1 Tax and IFN‐γ, PBMCs of HAM/TSP patients were cultured for 20 h and then were stained with antibodies for CD3, CD4, CD8, and CD25 (all from BD Biosciences) as previously reported.<xref rid="acn351437-bib-0009" ref-type="bibr"><sup>9</sup></xref> After treatment with fixation/permeabilization solution, the cells were stained with antibodies for Tax (Lt‐4) and IFN‐γ (BD Biosciences). All flow cytometric analysis was performed using an LSR II (BD Biosciences). The data were analyzed using FlowJo 10.5 software (FlowJo LLC).</p>
              </sec>
              <sec id="acn351437-sec-0012">
                <title>Lymphoproliferation assays</title>
                <p>Lymphoproliferation assay using [<sup>3</sup>H]‐thymidine was performed as previously described.<xref rid="acn351437-bib-0022" ref-type="bibr"><sup>22</sup></xref> PBMCs were cultured in triplicate and pulsed after 3–5 days of culture with 1 <italic toggle="yes">μ</italic>Ci [<sup>3</sup>H]‐thymidine. The average cpm from each of the wells was plotted. Lymphoproliferation assay was also performed using CFSE (CellTrace™ CFSE cell proliferation kit; Invitrogen) as previously described.<xref rid="acn351437-bib-0023" ref-type="bibr"><sup>23</sup></xref> After culturing for 4 and 5 days, the cells were stained with antibodies against CD3, CD4, CD8, and CD25 (all from BD Biosciences). The data were acquired on an LSRII flow cytometer (BD Biosciences) and were analyzed using FlowJo 10.5 software (FlowJo LLC).</p>
              </sec>
              <sec id="acn351437-sec-0013">
                <title>Statistics</title>
                <p>One‐way ANOVA with mixed effect analysis was used to compare: HTLV‐1 PVL, HTLV‐1 <italic toggle="yes">tax</italic>/<italic toggle="yes">HBZ</italic> mRNA, spontaneous lymphoproliferation, CD25<sup>+</sup> cell frequency in blood and CSF CD4<sup>+</sup> and CD8<sup>+</sup> T cells, CD122<sup>+</sup> cell frequency in CSF CD8<sup>+</sup> T cells of HAM/TSP patients, and antibody secreting B cells in CSF of HAM/TSP patients. A paired <italic toggle="yes">t</italic>‐test was used to compare: spontaneous CD4<sup>+</sup> T‐cell proliferation between baseline and month 6 time points, CD122<sup>+</sup> cell frequency in blood CD8<sup>+</sup> T cells, CD25<sup>+</sup> cell frequency in CSF CD4<sup>+</sup> T cells, Tax and Tax‐induced IFN‐γ expression in cultured PBMCs of HAM/TSP patients between baseline and at month 15 of the trial. A Pearson correlation test was used for compare between HTLV‐1 PVL in PBMCs and <italic toggle="yes">tax</italic> mRNA expression in cultured PBMCs of HAM/TSP patients. All statistical analysis was performed using Prism (GraphPad software).</p>
              </sec>
            </sec>
            <sec sec-type="results" id="acn351437-sec-0014">
              <title>Results</title>
              <sec id="acn351437-sec-0015">
                <title>Patients’ characteristics</title>
                <p>Of the 18 HAM/TSP patients enrolled into the clinical trial of raltegravir, 16 HAM/TSP patients completed the treatment period with at least one post‐treatment visit. Fourteen patients had a slowly progressive course of neurologic disease and two patients had rapid progression. The demographic characteristics of the study population are summarized in Table <xref rid="acn351437-tbl-0001" ref-type="table">1</xref>. Mean age of the study population was 53.5 years. The ratio of female to male was 10:6 and patients were predominantly African American. Mean disease duration of the study population was 10.8 years (Table <xref rid="acn351437-tbl-0001" ref-type="table">1</xref>).</p>
                <table-wrap position="float" id="acn351437-tbl-0001" content-type="Table">
                  <label>Table 1</label>
                  <caption>
                    <p>Demographics of HAM/TSP patients for raltegravir trial.</p>
                  </caption>
                  <table frame="hsides" rules="groups">
                    <col style="border-right:solid 1px #000000" span="1"/>
                    <col style="border-right:solid 1px #000000" span="1"/>
                    <col style="border-right:solid 1px #000000" span="1"/>
                    <col style="border-right:solid 1px #000000" span="1"/>
                    <col style="border-right:solid 1px #000000" span="1"/>
                    <col style="border-right:solid 1px #000000" span="1"/>
                    <col style="border-right:solid 1px #000000" span="1"/>
                    <thead valign="bottom">
                      <tr style="border-bottom:solid 1px #000000">
                        <th align="left" rowspan="2" valign="bottom" colspan="1">Patient No.</th>
                        <th align="center" style="border-bottom:solid 1px #000000" valign="bottom" rowspan="1" colspan="1">Age</th>
                        <th align="center" rowspan="2" valign="bottom" colspan="1">Gender</th>
                        <th align="center" rowspan="2" valign="bottom" colspan="1">Race/Ethnicity</th>
                        <th align="center" style="border-bottom:solid 1px #000000" valign="bottom" rowspan="1" colspan="1">Disease</th>
                        <th align="center" colspan="2" style="border-bottom:solid 1px #000000" valign="bottom" rowspan="1">HTLV‐1 PVL (%)</th>
                      </tr>
                      <tr style="border-bottom:solid 1px #000000">
                        <th align="center" valign="bottom" rowspan="1" colspan="1">(year)</th>
                        <th align="center" valign="bottom" rowspan="1" colspan="1">duration (year)</th>
                        <th align="center" valign="bottom" rowspan="1" colspan="1">PBMC<xref rid="acn351437-note-0003" ref-type="table-fn"><sup>1</sup></xref>
</th>
                        <th align="center" valign="bottom" rowspan="1" colspan="1">CSF</th>
                      </tr>
                    </thead>
                    <tbody>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">HAM #1</td>
                        <td align="left" rowspan="1" colspan="1">53</td>
                        <td align="left" rowspan="1" colspan="1">F</td>
                        <td align="left" rowspan="1" colspan="1">Black/African American</td>
                        <td align="char" char="." rowspan="1" colspan="1">8.4</td>
                        <td align="char" char="." rowspan="1" colspan="1">20.50</td>
                        <td align="char" char="." rowspan="1" colspan="1">45.06</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">HAM #2</td>
                        <td align="left" rowspan="1" colspan="1">54</td>
                        <td align="left" rowspan="1" colspan="1">F</td>
                        <td align="left" rowspan="1" colspan="1">Black/African American</td>
                        <td align="char" char="." rowspan="1" colspan="1">1.3</td>
                        <td align="char" char="." rowspan="1" colspan="1">15.34</td>
                        <td align="char" char="." rowspan="1" colspan="1">25.84</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">HAM #3</td>
                        <td align="left" rowspan="1" colspan="1">38</td>
                        <td align="left" rowspan="1" colspan="1">F</td>
                        <td align="left" rowspan="1" colspan="1">Black/African American</td>
                        <td align="char" char="." rowspan="1" colspan="1">1.2</td>
                        <td align="char" char="." rowspan="1" colspan="1">10.92</td>
                        <td align="char" char="." rowspan="1" colspan="1">50.95</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">HAM #4</td>
                        <td align="left" rowspan="1" colspan="1">48</td>
                        <td align="left" rowspan="1" colspan="1">F</td>
                        <td align="left" rowspan="1" colspan="1">Black/African American</td>
                        <td align="char" char="." rowspan="1" colspan="1">25.2</td>
                        <td align="char" char="." rowspan="1" colspan="1">10.63</td>
                        <td align="char" char="." rowspan="1" colspan="1">29.73</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">HAM #5</td>
                        <td align="left" rowspan="1" colspan="1">75</td>
                        <td align="left" rowspan="1" colspan="1">M</td>
                        <td align="left" rowspan="1" colspan="1">Black/African American</td>
                        <td align="char" char="." rowspan="1" colspan="1">9.8</td>
                        <td align="char" char="." rowspan="1" colspan="1">18.37</td>
                        <td align="char" char="." rowspan="1" colspan="1">25.70</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">HAM #7</td>
                        <td align="left" rowspan="1" colspan="1">68</td>
                        <td align="left" rowspan="1" colspan="1">M</td>
                        <td align="left" rowspan="1" colspan="1">White</td>
                        <td align="char" char="." rowspan="1" colspan="1">10.1</td>
                        <td align="char" char="." rowspan="1" colspan="1">16.60</td>
                        <td align="char" char="." rowspan="1" colspan="1">40.44</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">HAM #8</td>
                        <td align="left" rowspan="1" colspan="1">53</td>
                        <td align="left" rowspan="1" colspan="1">F</td>
                        <td align="left" rowspan="1" colspan="1">White</td>
                        <td align="char" char="." rowspan="1" colspan="1">4.6</td>
                        <td align="char" char="." rowspan="1" colspan="1">0.79</td>
                        <td align="char" char="." rowspan="1" colspan="1">7.48</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">HAM #9</td>
                        <td align="left" rowspan="1" colspan="1">66</td>
                        <td align="left" rowspan="1" colspan="1">F</td>
                        <td align="left" rowspan="1" colspan="1">Black/African American</td>
                        <td align="char" char="." rowspan="1" colspan="1">4.1</td>
                        <td align="char" char="." rowspan="1" colspan="1">11.57</td>
                        <td align="char" char="." rowspan="1" colspan="1">20.36</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">HAM #10</td>
                        <td align="left" rowspan="1" colspan="1">63</td>
                        <td align="left" rowspan="1" colspan="1">M</td>
                        <td align="left" rowspan="1" colspan="1">Black/African American</td>
                        <td align="char" char="." rowspan="1" colspan="1">20.2</td>
                        <td align="char" char="." rowspan="1" colspan="1">13.72</td>
                        <td align="char" char="." rowspan="1" colspan="1">51.68</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">HAM #12</td>
                        <td align="left" rowspan="1" colspan="1">42</td>
                        <td align="left" rowspan="1" colspan="1">F</td>
                        <td align="left" rowspan="1" colspan="1">Black/African American</td>
                        <td align="char" char="." rowspan="1" colspan="1">6.6</td>
                        <td align="char" char="." rowspan="1" colspan="1">12.76</td>
                        <td align="char" char="." rowspan="1" colspan="1">15.55</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">HAM #13</td>
                        <td align="left" rowspan="1" colspan="1">60</td>
                        <td align="left" rowspan="1" colspan="1">M</td>
                        <td align="left" rowspan="1" colspan="1">White</td>
                        <td align="char" char="." rowspan="1" colspan="1">20.6</td>
                        <td align="char" char="." rowspan="1" colspan="1">20.73</td>
                        <td align="char" char="." rowspan="1" colspan="1">23.17</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">HAM #14</td>
                        <td align="left" rowspan="1" colspan="1">55</td>
                        <td align="left" rowspan="1" colspan="1">M</td>
                        <td align="left" rowspan="1" colspan="1">Black/African American</td>
                        <td align="char" char="." rowspan="1" colspan="1">3.5</td>
                        <td align="char" char="." rowspan="1" colspan="1">33.40</td>
                        <td align="char" char="." rowspan="1" colspan="1">58.53</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">HAM #15</td>
                        <td align="left" rowspan="1" colspan="1">39</td>
                        <td align="left" rowspan="1" colspan="1">F</td>
                        <td align="left" rowspan="1" colspan="1">Hispanic</td>
                        <td align="char" char="." rowspan="1" colspan="1">18.3</td>
                        <td align="char" char="." rowspan="1" colspan="1">18.84</td>
                        <td align="char" char="." rowspan="1" colspan="1">23.00</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">HAM #16</td>
                        <td align="left" rowspan="1" colspan="1">48</td>
                        <td align="left" rowspan="1" colspan="1">F</td>
                        <td align="left" rowspan="1" colspan="1">Hispanic</td>
                        <td align="char" char="." rowspan="1" colspan="1">17.4</td>
                        <td align="char" char="." rowspan="1" colspan="1">10.11</td>
                        <td align="char" char="." rowspan="1" colspan="1">32.13</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">HAM #17</td>
                        <td align="left" rowspan="1" colspan="1">40</td>
                        <td align="left" rowspan="1" colspan="1">F</td>
                        <td align="left" rowspan="1" colspan="1">Black/African American</td>
                        <td align="char" char="." rowspan="1" colspan="1">14.0</td>
                        <td align="char" char="." rowspan="1" colspan="1">27.75</td>
                        <td align="char" char="." rowspan="1" colspan="1">34.42</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">HAM #18</td>
                        <td align="left" rowspan="1" colspan="1">54</td>
                        <td align="left" rowspan="1" colspan="1">M</td>
                        <td align="left" rowspan="1" colspan="1">Hispanic</td>
                        <td align="char" char="." rowspan="1" colspan="1">7.1</td>
                        <td align="char" char="." rowspan="1" colspan="1">17.07</td>
                        <td align="char" char="." rowspan="1" colspan="1">27.34</td>
                      </tr>
                    </tbody>
                  </table>
                  <table-wrap-foot id="acn351437-ntgp-0002">
                    <fn id="acn351437-note-0003">
                      <label>
                        <sup>1</sup>
                      </label>
                      <p>Average of two baselines (month 0 and up to 3 months before the treatment).</p>
                    </fn>
                  </table-wrap-foot>
                  <permissions>
                    <copyright-holder>John Wiley &amp; Sons, Ltd</copyright-holder>
                  </permissions>
                </table-wrap>
              </sec>
              <sec id="acn351437-sec-0016">
                <title>Safety and clinical effects of raltegravir</title>
                <p>Overall, the medication was well tolerated, with very few significant adverse events thought to be related to treatment. While on the study medication, a number of study participants (HAM #2, 3, 4, 7, 9, 10, 14, 16, 17) noted subjective improvements in a variety of symptoms at month 3 and/or month 6 time points, including increase in energy, ease with walking, improved spasticity, urination, and constipation. However, most objective clinical measurements were overall stable or showed clinical variations and slow progression typical of HAM/TSP patients (Table <xref rid="acn351437-tbl-0002" ref-type="table">2</xref>). Several patients showed very mild improvements in IPEC scores over the course of the trial (HAM #3, 5, 16, 17), and a few patients showed improved walking times during or after treatment (HAM #2, 4, 10, 16), but these findings are likely related to typical clinical fluctuations seen in HAM/TSP patients and may not be attributable to medication effect. No patients significantly worsened clinically during the trial, with the exception of one patient whose functional status declined after an unrelated hospitalization (HAM #13).</p>
                <table-wrap position="float" id="acn351437-tbl-0002" content-type="Table">
                  <label>Table 2</label>
                  <caption>
                    <p>Clinical parameters of HAM/TSP patients at baseline and post‐treatment of raltegravir.</p>
                  </caption>
                  <table frame="hsides" rules="groups">
                    <col style="border-right:solid 1px #000000" span="1"/>
                    <col style="border-right:solid 1px #000000" span="1"/>
                    <col style="border-right:solid 1px #000000" span="1"/>
                    <col style="border-right:solid 1px #000000" span="1"/>
                    <col style="border-right:solid 1px #000000" span="1"/>
                    <col style="border-right:solid 1px #000000" span="1"/>
                    <col style="border-right:solid 1px #000000" span="1"/>
                    <col style="border-right:solid 1px #000000" span="1"/>
                    <col style="border-right:solid 1px #000000" span="1"/>
                    <thead valign="top">
                      <tr style="border-bottom:solid 1px #000000">
                        <th align="left" valign="top" rowspan="1" colspan="1">Patient No.</th>
                        <th align="center" valign="top" rowspan="1" colspan="1">Time course</th>
                        <th align="center" valign="top" rowspan="1" colspan="1">EDSS</th>
                        <th align="center" valign="top" rowspan="1" colspan="1">SNRS</th>
                        <th align="center" valign="top" rowspan="1" colspan="1">T25‐FW</th>
                        <th align="center" valign="top" rowspan="1" colspan="1">IPEC</th>
                        <th align="center" valign="top" rowspan="1" colspan="1">AI</th>
                        <th align="center" valign="top" rowspan="1" colspan="1">9HPT Right</th>
                        <th align="center" valign="top" rowspan="1" colspan="1">9HPT Left</th>
                      </tr>
                    </thead>
                    <tbody>
                      <tr>
                        <td align="left" rowspan="5" colspan="1">HAM #1</td>
                        <td align="left" rowspan="1" colspan="1">Baseline</td>
                        <td align="left" rowspan="1" colspan="1">6.0</td>
                        <td align="left" rowspan="1" colspan="1">67</td>
                        <td align="left" rowspan="1" colspan="1">13.4</td>
                        <td align="left" rowspan="1" colspan="1">14</td>
                        <td align="left" rowspan="1" colspan="1">4.0</td>
                        <td align="left" rowspan="1" colspan="1">18.6</td>
                        <td align="left" rowspan="1" colspan="1">19.1</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Month 3</td>
                        <td align="left" rowspan="1" colspan="1">6.0</td>
                        <td align="left" rowspan="1" colspan="1">67</td>
                        <td align="left" rowspan="1" colspan="1">13.5</td>
                        <td align="left" rowspan="1" colspan="1">13</td>
                        <td align="left" rowspan="1" colspan="1">4.0</td>
                        <td align="left" rowspan="1" colspan="1">18.6</td>
                        <td align="left" rowspan="1" colspan="1">18.3</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Month 6</td>
                        <td align="left" rowspan="1" colspan="1">6.0</td>
                        <td align="left" rowspan="1" colspan="1">67</td>
                        <td align="left" rowspan="1" colspan="1">14.3</td>
                        <td align="left" rowspan="1" colspan="1">14</td>
                        <td align="left" rowspan="1" colspan="1">4.0</td>
                        <td align="left" rowspan="1" colspan="1">16.9</td>
                        <td align="left" rowspan="1" colspan="1">19.1</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Month 9</td>
                        <td align="left" rowspan="1" colspan="1">6.0</td>
                        <td align="left" rowspan="1" colspan="1">67</td>
                        <td align="left" rowspan="1" colspan="1">14.5</td>
                        <td align="left" rowspan="1" colspan="1">14</td>
                        <td align="left" rowspan="1" colspan="1">4.0</td>
                        <td align="left" rowspan="1" colspan="1">18.2</td>
                        <td align="left" rowspan="1" colspan="1">17.9</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Month 15</td>
                        <td align="left" rowspan="1" colspan="1">6.0</td>
                        <td align="left" rowspan="1" colspan="1">67</td>
                        <td align="left" rowspan="1" colspan="1">14.1</td>
                        <td align="left" rowspan="1" colspan="1">14</td>
                        <td align="left" rowspan="1" colspan="1">4.0</td>
                        <td align="left" rowspan="1" colspan="1">15.8</td>
                        <td align="left" rowspan="1" colspan="1">18.9</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="5" colspan="1">HAM #2</td>
                        <td align="left" rowspan="1" colspan="1">Baseline</td>
                        <td align="left" rowspan="1" colspan="1">6.5</td>
                        <td align="left" rowspan="1" colspan="1">57</td>
                        <td align="left" rowspan="1" colspan="1">33.1</td>
                        <td align="left" rowspan="1" colspan="1">22</td>
                        <td align="left" rowspan="1" colspan="1">6.0</td>
                        <td align="left" rowspan="1" colspan="1">19.1</td>
                        <td align="left" rowspan="1" colspan="1">20.7</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Month 3</td>
                        <td align="left" rowspan="1" colspan="1">6.5</td>
                        <td align="left" rowspan="1" colspan="1">60</td>
                        <td align="left" rowspan="1" colspan="1">39.2</td>
                        <td align="left" rowspan="1" colspan="1">18</td>
                        <td align="left" rowspan="1" colspan="1">6.0</td>
                        <td align="left" rowspan="1" colspan="1">19.6</td>
                        <td align="left" rowspan="1" colspan="1">19.6</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Month 6</td>
                        <td align="left" rowspan="1" colspan="1">6.5</td>
                        <td align="left" rowspan="1" colspan="1">60</td>
                        <td align="left" rowspan="1" colspan="1">39.5</td>
                        <td align="left" rowspan="1" colspan="1">23</td>
                        <td align="left" rowspan="1" colspan="1">6.0</td>
                        <td align="left" rowspan="1" colspan="1">17.9</td>
                        <td align="left" rowspan="1" colspan="1">21.0</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Month 9</td>
                        <td align="left" rowspan="1" colspan="1">6.5</td>
                        <td align="left" rowspan="1" colspan="1">54</td>
                        <td align="left" rowspan="1" colspan="1">33.1</td>
                        <td align="left" rowspan="1" colspan="1">23</td>
                        <td align="left" rowspan="1" colspan="1">6.0</td>
                        <td align="left" rowspan="1" colspan="1">19.2</td>
                        <td align="left" rowspan="1" colspan="1">20.6</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Month 15</td>
                        <td align="left" rowspan="1" colspan="1">6.5</td>
                        <td align="left" rowspan="1" colspan="1">57</td>
                        <td align="left" rowspan="1" colspan="1">33.5</td>
                        <td align="left" rowspan="1" colspan="1">22</td>
                        <td align="left" rowspan="1" colspan="1">6.0</td>
                        <td align="left" rowspan="1" colspan="1">19.8</td>
                        <td align="left" rowspan="1" colspan="1">21.2</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="5" colspan="1">HAM #3</td>
                        <td align="left" rowspan="1" colspan="1">Baseline</td>
                        <td align="left" rowspan="1" colspan="1">6.0</td>
                        <td align="left" rowspan="1" colspan="1">70</td>
                        <td align="left" rowspan="1" colspan="1">23.5</td>
                        <td align="left" rowspan="1" colspan="1">12</td>
                        <td align="left" rowspan="1" colspan="1">5.0</td>
                        <td align="left" rowspan="1" colspan="1">22.3</td>
                        <td align="left" rowspan="1" colspan="1">21.3</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Month 3</td>
                        <td align="left" rowspan="1" colspan="1">6.0</td>
                        <td align="left" rowspan="1" colspan="1">74</td>
                        <td align="left" rowspan="1" colspan="1">22.7</td>
                        <td align="left" rowspan="1" colspan="1">11</td>
                        <td align="left" rowspan="1" colspan="1">5.0</td>
                        <td align="left" rowspan="1" colspan="1">19.8</td>
                        <td align="left" rowspan="1" colspan="1">18.6</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Month 6</td>
                        <td align="left" rowspan="1" colspan="1">6.0</td>
                        <td align="left" rowspan="1" colspan="1">74</td>
                        <td align="left" rowspan="1" colspan="1">26.2</td>
                        <td align="left" rowspan="1" colspan="1">11</td>
                        <td align="left" rowspan="1" colspan="1">5.0</td>
                        <td align="left" rowspan="1" colspan="1">19.2</td>
                        <td align="left" rowspan="1" colspan="1">20.7</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Month 9</td>
                        <td align="left" rowspan="1" colspan="1">6.0</td>
                        <td align="left" rowspan="1" colspan="1">74</td>
                        <td align="left" rowspan="1" colspan="1">18.3</td>
                        <td align="left" rowspan="1" colspan="1">11</td>
                        <td align="left" rowspan="1" colspan="1">4.0</td>
                        <td align="left" rowspan="1" colspan="1">19.2</td>
                        <td align="left" rowspan="1" colspan="1">21.8</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Month 15</td>
                        <td align="left" rowspan="1" colspan="1">6.0</td>
                        <td align="left" rowspan="1" colspan="1">74</td>
                        <td align="left" rowspan="1" colspan="1">21.2</td>
                        <td align="left" rowspan="1" colspan="1">11</td>
                        <td align="left" rowspan="1" colspan="1">5.0</td>
                        <td align="left" rowspan="1" colspan="1">19.7</td>
                        <td align="left" rowspan="1" colspan="1">19.9</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="5" colspan="1">HAM #4</td>
                        <td align="left" rowspan="1" colspan="1">Baseline</td>
                        <td align="left" rowspan="1" colspan="1">6.5</td>
                        <td align="left" rowspan="1" colspan="1">61</td>
                        <td align="left" rowspan="1" colspan="1">20.7</td>
                        <td align="left" rowspan="1" colspan="1">15</td>
                        <td align="left" rowspan="1" colspan="1">6.0</td>
                        <td align="left" rowspan="1" colspan="1">23.6</td>
                        <td align="left" rowspan="1" colspan="1">26.8</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Month 3</td>
                        <td align="left" rowspan="1" colspan="1">6.5</td>
                        <td align="left" rowspan="1" colspan="1">61</td>
                        <td align="left" rowspan="1" colspan="1">21.6</td>
                        <td align="left" rowspan="1" colspan="1">15</td>
                        <td align="left" rowspan="1" colspan="1">6.0</td>
                        <td align="left" rowspan="1" colspan="1">20.4</td>
                        <td align="left" rowspan="1" colspan="1">23.3</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Month 6</td>
                        <td align="left" rowspan="1" colspan="1">6.5</td>
                        <td align="left" rowspan="1" colspan="1">64</td>
                        <td align="left" rowspan="1" colspan="1">21.4</td>
                        <td align="left" rowspan="1" colspan="1">15</td>
                        <td align="left" rowspan="1" colspan="1">6.0</td>
                        <td align="left" rowspan="1" colspan="1">22.2</td>
                        <td align="left" rowspan="1" colspan="1">23.5</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Month 9</td>
                        <td align="left" rowspan="1" colspan="1">6.5</td>
                        <td align="left" rowspan="1" colspan="1">73</td>
                        <td align="left" rowspan="1" colspan="1">16.8</td>
                        <td align="left" rowspan="1" colspan="1">15</td>
                        <td align="left" rowspan="1" colspan="1">6.0</td>
                        <td align="left" rowspan="1" colspan="1">NA</td>
                        <td align="left" rowspan="1" colspan="1">NA</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Month 15</td>
                        <td align="left" rowspan="1" colspan="1">6.5</td>
                        <td align="left" rowspan="1" colspan="1">73</td>
                        <td align="left" rowspan="1" colspan="1">19.3</td>
                        <td align="left" rowspan="1" colspan="1">15</td>
                        <td align="left" rowspan="1" colspan="1">6.0</td>
                        <td align="left" rowspan="1" colspan="1">18.7</td>
                        <td align="left" rowspan="1" colspan="1">23.5</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="5" colspan="1">HAM #5</td>
                        <td align="left" rowspan="1" colspan="1">Baseline</td>
                        <td align="left" rowspan="1" colspan="1">6.0</td>
                        <td align="left" rowspan="1" colspan="1">56</td>
                        <td align="left" rowspan="1" colspan="1">5.3</td>
                        <td align="left" rowspan="1" colspan="1">13</td>
                        <td align="left" rowspan="1" colspan="1">2.0</td>
                        <td align="left" rowspan="1" colspan="1">21.4</td>
                        <td align="left" rowspan="1" colspan="1">25.3</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Month 3</td>
                        <td align="left" rowspan="1" colspan="1">6.0</td>
                        <td align="left" rowspan="1" colspan="1">56</td>
                        <td align="left" rowspan="1" colspan="1">6.0</td>
                        <td align="left" rowspan="1" colspan="1">13</td>
                        <td align="left" rowspan="1" colspan="1">2.0</td>
                        <td align="left" rowspan="1" colspan="1">19.3</td>
                        <td align="left" rowspan="1" colspan="1">26.2</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Month 6</td>
                        <td align="left" rowspan="1" colspan="1">6.0</td>
                        <td align="left" rowspan="1" colspan="1">56</td>
                        <td align="left" rowspan="1" colspan="1">6.1</td>
                        <td align="left" rowspan="1" colspan="1">13</td>
                        <td align="left" rowspan="1" colspan="1">2.0</td>
                        <td align="left" rowspan="1" colspan="1">19.8</td>
                        <td align="left" rowspan="1" colspan="1">23.3</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Month 9</td>
                        <td align="left" rowspan="1" colspan="1">6.0</td>
                        <td align="left" rowspan="1" colspan="1">56</td>
                        <td align="left" rowspan="1" colspan="1">6.5</td>
                        <td align="left" rowspan="1" colspan="1">13</td>
                        <td align="left" rowspan="1" colspan="1">2.0</td>
                        <td align="left" rowspan="1" colspan="1">21.2</td>
                        <td align="left" rowspan="1" colspan="1">23.9</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Month 15</td>
                        <td align="left" rowspan="1" colspan="1">6.0</td>
                        <td align="left" rowspan="1" colspan="1">68</td>
                        <td align="left" rowspan="1" colspan="1">6.3</td>
                        <td align="left" rowspan="1" colspan="1">12</td>
                        <td align="left" rowspan="1" colspan="1">2.0</td>
                        <td align="left" rowspan="1" colspan="1">19.4</td>
                        <td align="left" rowspan="1" colspan="1">24.7</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="5" colspan="1">HAM #7</td>
                        <td align="left" rowspan="1" colspan="1">Baseline</td>
                        <td align="left" rowspan="1" colspan="1">6.0</td>
                        <td align="left" rowspan="1" colspan="1">76</td>
                        <td align="left" rowspan="1" colspan="1">9.0</td>
                        <td align="left" rowspan="1" colspan="1">12</td>
                        <td align="left" rowspan="1" colspan="1">4.0</td>
                        <td align="left" rowspan="1" colspan="1">21.8</td>
                        <td align="left" rowspan="1" colspan="1">22.8</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Month 3</td>
                        <td align="left" rowspan="1" colspan="1">6.0</td>
                        <td align="left" rowspan="1" colspan="1">76</td>
                        <td align="left" rowspan="1" colspan="1">11.2</td>
                        <td align="left" rowspan="1" colspan="1">12</td>
                        <td align="left" rowspan="1" colspan="1">4.0</td>
                        <td align="left" rowspan="1" colspan="1">22.0</td>
                        <td align="left" rowspan="1" colspan="1">24.6</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Month 6</td>
                        <td align="left" rowspan="1" colspan="1">6.0</td>
                        <td align="left" rowspan="1" colspan="1">76</td>
                        <td align="left" rowspan="1" colspan="1">10.1</td>
                        <td align="left" rowspan="1" colspan="1">14</td>
                        <td align="left" rowspan="1" colspan="1">4.0</td>
                        <td align="left" rowspan="1" colspan="1">21.1</td>
                        <td align="left" rowspan="1" colspan="1">25.2</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Month 9</td>
                        <td align="left" rowspan="1" colspan="1">6.0</td>
                        <td align="left" rowspan="1" colspan="1">76</td>
                        <td align="left" rowspan="1" colspan="1">7.9</td>
                        <td align="left" rowspan="1" colspan="1">13</td>
                        <td align="left" rowspan="1" colspan="1">4.0</td>
                        <td align="left" rowspan="1" colspan="1">22.2</td>
                        <td align="left" rowspan="1" colspan="1">28.9</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Month 15</td>
                        <td align="left" rowspan="1" colspan="1">NA</td>
                        <td align="left" rowspan="1" colspan="1">NA</td>
                        <td align="left" rowspan="1" colspan="1">NA</td>
                        <td align="left" rowspan="1" colspan="1">NA</td>
                        <td align="left" rowspan="1" colspan="1">NA</td>
                        <td align="left" rowspan="1" colspan="1">NA</td>
                        <td align="left" rowspan="1" colspan="1">NA</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="5" colspan="1">HAM #8</td>
                        <td align="left" rowspan="1" colspan="1">Baseline</td>
                        <td align="left" rowspan="1" colspan="1">6.0</td>
                        <td align="left" rowspan="1" colspan="1">79</td>
                        <td align="left" rowspan="1" colspan="1">15.5</td>
                        <td align="left" rowspan="1" colspan="1">13</td>
                        <td align="left" rowspan="1" colspan="1">4.0</td>
                        <td align="left" rowspan="1" colspan="1">24.7</td>
                        <td align="left" rowspan="1" colspan="1">25.6</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Month 3</td>
                        <td align="left" rowspan="1" colspan="1">6.0</td>
                        <td align="left" rowspan="1" colspan="1">79</td>
                        <td align="left" rowspan="1" colspan="1">14.3</td>
                        <td align="left" rowspan="1" colspan="1">13</td>
                        <td align="left" rowspan="1" colspan="1">4.0</td>
                        <td align="left" rowspan="1" colspan="1">22.8</td>
                        <td align="left" rowspan="1" colspan="1">23.8</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Month 6</td>
                        <td align="left" rowspan="1" colspan="1">6.0</td>
                        <td align="left" rowspan="1" colspan="1">79</td>
                        <td align="left" rowspan="1" colspan="1">14.6</td>
                        <td align="left" rowspan="1" colspan="1">13</td>
                        <td align="left" rowspan="1" colspan="1">4.0</td>
                        <td align="left" rowspan="1" colspan="1">23.8</td>
                        <td align="left" rowspan="1" colspan="1">23.1</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Month 9</td>
                        <td align="left" rowspan="1" colspan="1">6.0</td>
                        <td align="left" rowspan="1" colspan="1">79</td>
                        <td align="left" rowspan="1" colspan="1">15.1</td>
                        <td align="left" rowspan="1" colspan="1">13</td>
                        <td align="left" rowspan="1" colspan="1">4.0</td>
                        <td align="left" rowspan="1" colspan="1">24.7</td>
                        <td align="left" rowspan="1" colspan="1">24.5</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Month 15</td>
                        <td align="left" rowspan="1" colspan="1">6.0</td>
                        <td align="left" rowspan="1" colspan="1">79</td>
                        <td align="left" rowspan="1" colspan="1">14.7</td>
                        <td align="left" rowspan="1" colspan="1">13</td>
                        <td align="left" rowspan="1" colspan="1">4.0</td>
                        <td align="left" rowspan="1" colspan="1">24.3</td>
                        <td align="left" rowspan="1" colspan="1">24.9</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="5" colspan="1">HAM #9</td>
                        <td align="left" rowspan="1" colspan="1">Baseline</td>
                        <td align="left" rowspan="1" colspan="1">8.0</td>
                        <td align="left" rowspan="1" colspan="1">65</td>
                        <td align="left" rowspan="1" colspan="1">NA</td>
                        <td align="left" rowspan="1" colspan="1">25</td>
                        <td align="left" rowspan="1" colspan="1">8.0</td>
                        <td align="left" rowspan="1" colspan="1">24.6</td>
                        <td align="left" rowspan="1" colspan="1">27.8</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Month 3</td>
                        <td align="left" rowspan="1" colspan="1">8.0</td>
                        <td align="left" rowspan="1" colspan="1">55</td>
                        <td align="left" rowspan="1" colspan="1">NA</td>
                        <td align="left" rowspan="1" colspan="1">25</td>
                        <td align="left" rowspan="1" colspan="1">8.0</td>
                        <td align="left" rowspan="1" colspan="1">21.8</td>
                        <td align="left" rowspan="1" colspan="1">23.2</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Month 6</td>
                        <td align="left" rowspan="1" colspan="1">8.0</td>
                        <td align="left" rowspan="1" colspan="1">55</td>
                        <td align="left" rowspan="1" colspan="1">NA</td>
                        <td align="left" rowspan="1" colspan="1">25</td>
                        <td align="left" rowspan="1" colspan="1">8.0</td>
                        <td align="left" rowspan="1" colspan="1">21.5</td>
                        <td align="left" rowspan="1" colspan="1">21.7</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Month 9</td>
                        <td align="left" rowspan="1" colspan="1">8.0</td>
                        <td align="left" rowspan="1" colspan="1">55</td>
                        <td align="left" rowspan="1" colspan="1">NA</td>
                        <td align="left" rowspan="1" colspan="1">25</td>
                        <td align="left" rowspan="1" colspan="1">8.0</td>
                        <td align="left" rowspan="1" colspan="1">20.2</td>
                        <td align="left" rowspan="1" colspan="1">23.1</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Month 15</td>
                        <td align="left" rowspan="1" colspan="1">8.0</td>
                        <td align="left" rowspan="1" colspan="1">55</td>
                        <td align="left" rowspan="1" colspan="1">NA</td>
                        <td align="left" rowspan="1" colspan="1">25</td>
                        <td align="left" rowspan="1" colspan="1">8.0</td>
                        <td align="left" rowspan="1" colspan="1">20.5</td>
                        <td align="left" rowspan="1" colspan="1">21.3</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="5" colspan="1">HAM #10</td>
                        <td align="left" rowspan="1" colspan="1">Baseline</td>
                        <td align="left" rowspan="1" colspan="1">6.0</td>
                        <td align="left" rowspan="1" colspan="1">41</td>
                        <td align="left" rowspan="1" colspan="1">38.4</td>
                        <td align="left" rowspan="1" colspan="1">14</td>
                        <td align="left" rowspan="1" colspan="1">5.0</td>
                        <td align="left" rowspan="1" colspan="1">28.7</td>
                        <td align="left" rowspan="1" colspan="1">25.9</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Month 3</td>
                        <td align="left" rowspan="1" colspan="1">6.0</td>
                        <td align="left" rowspan="1" colspan="1">44</td>
                        <td align="left" rowspan="1" colspan="1">26.7</td>
                        <td align="left" rowspan="1" colspan="1">14</td>
                        <td align="left" rowspan="1" colspan="1">5.0</td>
                        <td align="left" rowspan="1" colspan="1">28.0</td>
                        <td align="left" rowspan="1" colspan="1">30.8</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Month 6</td>
                        <td align="left" rowspan="1" colspan="1">6.0</td>
                        <td align="left" rowspan="1" colspan="1">48</td>
                        <td align="left" rowspan="1" colspan="1">43.7</td>
                        <td align="left" rowspan="1" colspan="1">14</td>
                        <td align="left" rowspan="1" colspan="1">5.0</td>
                        <td align="left" rowspan="1" colspan="1">29.5</td>
                        <td align="left" rowspan="1" colspan="1">32.0</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Month 9</td>
                        <td align="left" rowspan="1" colspan="1">6.0</td>
                        <td align="left" rowspan="1" colspan="1">48</td>
                        <td align="left" rowspan="1" colspan="1">37.1</td>
                        <td align="left" rowspan="1" colspan="1">14</td>
                        <td align="left" rowspan="1" colspan="1">5.0</td>
                        <td align="left" rowspan="1" colspan="1">31.5</td>
                        <td align="left" rowspan="1" colspan="1">35.1</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Month 15</td>
                        <td align="left" rowspan="1" colspan="1">6.0</td>
                        <td align="left" rowspan="1" colspan="1">48</td>
                        <td align="left" rowspan="1" colspan="1">33.4</td>
                        <td align="left" rowspan="1" colspan="1">14</td>
                        <td align="left" rowspan="1" colspan="1">5.0</td>
                        <td align="left" rowspan="1" colspan="1">29.1</td>
                        <td align="left" rowspan="1" colspan="1">38.2</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="5" colspan="1">HAM #12</td>
                        <td align="left" rowspan="1" colspan="1">Baseline</td>
                        <td align="left" rowspan="1" colspan="1">7.0</td>
                        <td align="left" rowspan="1" colspan="1">62</td>
                        <td align="left" rowspan="1" colspan="1">NA</td>
                        <td align="left" rowspan="1" colspan="1">22</td>
                        <td align="left" rowspan="1" colspan="1">8.0</td>
                        <td align="left" rowspan="1" colspan="1">21.8</td>
                        <td align="left" rowspan="1" colspan="1">22.2</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Month 3</td>
                        <td align="left" rowspan="1" colspan="1">7.0</td>
                        <td align="left" rowspan="1" colspan="1">60</td>
                        <td align="left" rowspan="1" colspan="1">NA</td>
                        <td align="left" rowspan="1" colspan="1">22</td>
                        <td align="left" rowspan="1" colspan="1">8.0</td>
                        <td align="left" rowspan="1" colspan="1">26.0</td>
                        <td align="left" rowspan="1" colspan="1">31.4</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Month 6</td>
                        <td align="left" rowspan="1" colspan="1">7.0</td>
                        <td align="left" rowspan="1" colspan="1">60</td>
                        <td align="left" rowspan="1" colspan="1">NA</td>
                        <td align="left" rowspan="1" colspan="1">22</td>
                        <td align="left" rowspan="1" colspan="1">8.0</td>
                        <td align="left" rowspan="1" colspan="1">NA</td>
                        <td align="left" rowspan="1" colspan="1">26.8</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Month 9</td>
                        <td align="left" rowspan="1" colspan="1">7.0</td>
                        <td align="left" rowspan="1" colspan="1">60</td>
                        <td align="left" rowspan="1" colspan="1">NA</td>
                        <td align="left" rowspan="1" colspan="1">22</td>
                        <td align="left" rowspan="1" colspan="1">8.0</td>
                        <td align="left" rowspan="1" colspan="1">21.9</td>
                        <td align="left" rowspan="1" colspan="1">26.0</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Month 15</td>
                        <td align="left" rowspan="1" colspan="1">7.0</td>
                        <td align="left" rowspan="1" colspan="1">56</td>
                        <td align="left" rowspan="1" colspan="1">NA</td>
                        <td align="left" rowspan="1" colspan="1">23</td>
                        <td align="left" rowspan="1" colspan="1">8.0</td>
                        <td align="left" rowspan="1" colspan="1">25.5</td>
                        <td align="left" rowspan="1" colspan="1">27.5</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="5" colspan="1">HAM #13</td>
                        <td align="left" rowspan="1" colspan="1">Baseline</td>
                        <td align="left" rowspan="1" colspan="1">6.5</td>
                        <td align="left" rowspan="1" colspan="1">42</td>
                        <td align="left" rowspan="1" colspan="1">NA</td>
                        <td align="left" rowspan="1" colspan="1">19</td>
                        <td align="left" rowspan="1" colspan="1">6.0</td>
                        <td align="left" rowspan="1" colspan="1">28.1</td>
                        <td align="left" rowspan="1" colspan="1">24.7</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Month 3</td>
                        <td align="left" rowspan="1" colspan="1">6.5</td>
                        <td align="left" rowspan="1" colspan="1">42</td>
                        <td align="left" rowspan="1" colspan="1">NA</td>
                        <td align="left" rowspan="1" colspan="1">19</td>
                        <td align="left" rowspan="1" colspan="1">6.0</td>
                        <td align="left" rowspan="1" colspan="1">24.4</td>
                        <td align="left" rowspan="1" colspan="1">31.6</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Month 6</td>
                        <td align="left" rowspan="1" colspan="1">6.5</td>
                        <td align="left" rowspan="1" colspan="1">42</td>
                        <td align="left" rowspan="1" colspan="1">NA</td>
                        <td align="left" rowspan="1" colspan="1">19</td>
                        <td align="left" rowspan="1" colspan="1">6.0</td>
                        <td align="left" rowspan="1" colspan="1">28.0</td>
                        <td align="left" rowspan="1" colspan="1">24.7</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Month 9</td>
                        <td align="left" rowspan="1" colspan="1">7.0</td>
                        <td align="left" rowspan="1" colspan="1">42</td>
                        <td align="left" rowspan="1" colspan="1">NA</td>
                        <td align="left" rowspan="1" colspan="1">22</td>
                        <td align="left" rowspan="1" colspan="1">6.0</td>
                        <td align="left" rowspan="1" colspan="1">27.4</td>
                        <td align="left" rowspan="1" colspan="1">25.7</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Month 15</td>
                        <td align="left" rowspan="1" colspan="1">7.0</td>
                        <td align="left" rowspan="1" colspan="1">42</td>
                        <td align="left" rowspan="1" colspan="1">NA</td>
                        <td align="left" rowspan="1" colspan="1">22</td>
                        <td align="left" rowspan="1" colspan="1">6.0</td>
                        <td align="left" rowspan="1" colspan="1">34.0</td>
                        <td align="left" rowspan="1" colspan="1">29.4</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="5" colspan="1">HAM #14</td>
                        <td align="left" rowspan="1" colspan="1">Baseline</td>
                        <td align="left" rowspan="1" colspan="1">8.0</td>
                        <td align="left" rowspan="1" colspan="1">51</td>
                        <td align="left" rowspan="1" colspan="1">NA</td>
                        <td align="left" rowspan="1" colspan="1">23</td>
                        <td align="left" rowspan="1" colspan="1">8.0</td>
                        <td align="left" rowspan="1" colspan="1">19.8</td>
                        <td align="left" rowspan="1" colspan="1">20.4</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Month 3</td>
                        <td align="left" rowspan="1" colspan="1">8.0</td>
                        <td align="left" rowspan="1" colspan="1">51</td>
                        <td align="left" rowspan="1" colspan="1">NA</td>
                        <td align="left" rowspan="1" colspan="1">23</td>
                        <td align="left" rowspan="1" colspan="1">8.0</td>
                        <td align="left" rowspan="1" colspan="1">18.2</td>
                        <td align="left" rowspan="1" colspan="1">19.7</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Month 6</td>
                        <td align="left" rowspan="1" colspan="1">8.0</td>
                        <td align="left" rowspan="1" colspan="1">51</td>
                        <td align="left" rowspan="1" colspan="1">NA</td>
                        <td align="left" rowspan="1" colspan="1">23</td>
                        <td align="left" rowspan="1" colspan="1">8.0</td>
                        <td align="left" rowspan="1" colspan="1">18.8</td>
                        <td align="left" rowspan="1" colspan="1">19.3</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Month 9</td>
                        <td align="left" rowspan="1" colspan="1">8.0</td>
                        <td align="left" rowspan="1" colspan="1">51</td>
                        <td align="left" rowspan="1" colspan="1">NA</td>
                        <td align="left" rowspan="1" colspan="1">23</td>
                        <td align="left" rowspan="1" colspan="1">8.0</td>
                        <td align="left" rowspan="1" colspan="1">20.9</td>
                        <td align="left" rowspan="1" colspan="1">21.2</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Month 15</td>
                        <td align="left" rowspan="1" colspan="1">8.0</td>
                        <td align="left" rowspan="1" colspan="1">51</td>
                        <td align="left" rowspan="1" colspan="1">NA</td>
                        <td align="left" rowspan="1" colspan="1">24</td>
                        <td align="left" rowspan="1" colspan="1">8.0</td>
                        <td align="left" rowspan="1" colspan="1">16.6</td>
                        <td align="left" rowspan="1" colspan="1">21.1</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="5" colspan="1">HAM #15</td>
                        <td align="left" rowspan="1" colspan="1">Baseline</td>
                        <td align="left" rowspan="1" colspan="1">6.5</td>
                        <td align="left" rowspan="1" colspan="1">58</td>
                        <td align="left" rowspan="1" colspan="1">17.2</td>
                        <td align="left" rowspan="1" colspan="1">17</td>
                        <td align="left" rowspan="1" colspan="1">6.0</td>
                        <td align="left" rowspan="1" colspan="1">25.0</td>
                        <td align="left" rowspan="1" colspan="1">25.5</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Month 3</td>
                        <td align="left" rowspan="1" colspan="1">6.5</td>
                        <td align="left" rowspan="1" colspan="1">58</td>
                        <td align="left" rowspan="1" colspan="1">16.7</td>
                        <td align="left" rowspan="1" colspan="1">19</td>
                        <td align="left" rowspan="1" colspan="1">6.0</td>
                        <td align="left" rowspan="1" colspan="1">20.7</td>
                        <td align="left" rowspan="1" colspan="1">21.3</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Month 6</td>
                        <td align="left" rowspan="1" colspan="1">6.5</td>
                        <td align="left" rowspan="1" colspan="1">58</td>
                        <td align="left" rowspan="1" colspan="1">17.2</td>
                        <td align="left" rowspan="1" colspan="1">19</td>
                        <td align="left" rowspan="1" colspan="1">6.0</td>
                        <td align="left" rowspan="1" colspan="1">21.3</td>
                        <td align="left" rowspan="1" colspan="1">23.0</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Month 9</td>
                        <td align="left" rowspan="1" colspan="1">6.5</td>
                        <td align="left" rowspan="1" colspan="1">58</td>
                        <td align="left" rowspan="1" colspan="1">18.2</td>
                        <td align="left" rowspan="1" colspan="1">20</td>
                        <td align="left" rowspan="1" colspan="1">6.0</td>
                        <td align="left" rowspan="1" colspan="1">21.3</td>
                        <td align="left" rowspan="1" colspan="1">22.9</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Month 15</td>
                        <td align="left" rowspan="1" colspan="1">6.5</td>
                        <td align="left" rowspan="1" colspan="1">58</td>
                        <td align="left" rowspan="1" colspan="1">17.5</td>
                        <td align="left" rowspan="1" colspan="1">20</td>
                        <td align="left" rowspan="1" colspan="1">6.0</td>
                        <td align="left" rowspan="1" colspan="1">18.5</td>
                        <td align="left" rowspan="1" colspan="1">19.3</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="5" colspan="1">HAM #16</td>
                        <td align="left" rowspan="1" colspan="1">Baseline</td>
                        <td align="left" rowspan="1" colspan="1">6.5</td>
                        <td align="left" rowspan="1" colspan="1">66</td>
                        <td align="left" rowspan="1" colspan="1">33.5</td>
                        <td align="left" rowspan="1" colspan="1">17</td>
                        <td align="left" rowspan="1" colspan="1">6.0</td>
                        <td align="left" rowspan="1" colspan="1">26.6</td>
                        <td align="left" rowspan="1" colspan="1">29.2</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Month 3</td>
                        <td align="left" rowspan="1" colspan="1">6.5</td>
                        <td align="left" rowspan="1" colspan="1">66</td>
                        <td align="left" rowspan="1" colspan="1">30.0</td>
                        <td align="left" rowspan="1" colspan="1">17</td>
                        <td align="left" rowspan="1" colspan="1">6.0</td>
                        <td align="left" rowspan="1" colspan="1">25.2</td>
                        <td align="left" rowspan="1" colspan="1">27.1</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Month 6</td>
                        <td align="left" rowspan="1" colspan="1">6.5</td>
                        <td align="left" rowspan="1" colspan="1">66</td>
                        <td align="left" rowspan="1" colspan="1">12.7</td>
                        <td align="left" rowspan="1" colspan="1">16</td>
                        <td align="left" rowspan="1" colspan="1">5.0</td>
                        <td align="left" rowspan="1" colspan="1">26.1</td>
                        <td align="left" rowspan="1" colspan="1">29.6</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Month 9</td>
                        <td align="left" rowspan="1" colspan="1">6.5</td>
                        <td align="left" rowspan="1" colspan="1">66</td>
                        <td align="left" rowspan="1" colspan="1">19.1</td>
                        <td align="left" rowspan="1" colspan="1">16</td>
                        <td align="left" rowspan="1" colspan="1">5.0</td>
                        <td align="left" rowspan="1" colspan="1">24.1</td>
                        <td align="left" rowspan="1" colspan="1">24.5</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Month 15</td>
                        <td align="left" rowspan="1" colspan="1">6.5</td>
                        <td align="left" rowspan="1" colspan="1">66</td>
                        <td align="left" rowspan="1" colspan="1">26.5</td>
                        <td align="left" rowspan="1" colspan="1">16</td>
                        <td align="left" rowspan="1" colspan="1">6.0</td>
                        <td align="left" rowspan="1" colspan="1">22.0</td>
                        <td align="left" rowspan="1" colspan="1">26.0</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="5" colspan="1">HAM #17</td>
                        <td align="left" rowspan="1" colspan="1">Baseline</td>
                        <td align="left" rowspan="1" colspan="1">7.0</td>
                        <td align="left" rowspan="1" colspan="1">55</td>
                        <td align="left" rowspan="1" colspan="1">62.0</td>
                        <td align="left" rowspan="1" colspan="1">17</td>
                        <td align="left" rowspan="1" colspan="1">6.0</td>
                        <td align="left" rowspan="1" colspan="1">24.2</td>
                        <td align="left" rowspan="1" colspan="1">27.1</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Month 3</td>
                        <td align="left" rowspan="1" colspan="1">7.0</td>
                        <td align="left" rowspan="1" colspan="1">58</td>
                        <td align="left" rowspan="1" colspan="1">37.5</td>
                        <td align="left" rowspan="1" colspan="1">19</td>
                        <td align="left" rowspan="1" colspan="1">7.0</td>
                        <td align="left" rowspan="1" colspan="1">22.9</td>
                        <td align="left" rowspan="1" colspan="1">23.0</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Month 6</td>
                        <td align="left" rowspan="1" colspan="1">7.0</td>
                        <td align="left" rowspan="1" colspan="1">55</td>
                        <td align="left" rowspan="1" colspan="1">47.0</td>
                        <td align="left" rowspan="1" colspan="1">17</td>
                        <td align="left" rowspan="1" colspan="1">7.0</td>
                        <td align="left" rowspan="1" colspan="1">22.7</td>
                        <td align="left" rowspan="1" colspan="1">23.4</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Month 9</td>
                        <td align="left" rowspan="1" colspan="1">7.0</td>
                        <td align="left" rowspan="1" colspan="1">55</td>
                        <td align="left" rowspan="1" colspan="1">48.9</td>
                        <td align="left" rowspan="1" colspan="1">17</td>
                        <td align="left" rowspan="1" colspan="1">7.0</td>
                        <td align="left" rowspan="1" colspan="1">21.5</td>
                        <td align="left" rowspan="1" colspan="1">23.4</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Month 15</td>
                        <td align="left" rowspan="1" colspan="1">7.0</td>
                        <td align="left" rowspan="1" colspan="1">66</td>
                        <td align="left" rowspan="1" colspan="1">53.5</td>
                        <td align="left" rowspan="1" colspan="1">17</td>
                        <td align="left" rowspan="1" colspan="1">7.0</td>
                        <td align="left" rowspan="1" colspan="1">21.2</td>
                        <td align="left" rowspan="1" colspan="1">23.4</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="5" colspan="1">HAM #18</td>
                        <td align="left" rowspan="1" colspan="1">Baseline</td>
                        <td align="left" rowspan="1" colspan="1">6.0</td>
                        <td align="left" rowspan="1" colspan="1">80</td>
                        <td align="left" rowspan="1" colspan="1">10.6</td>
                        <td align="left" rowspan="1" colspan="1">13</td>
                        <td align="left" rowspan="1" colspan="1">4.0</td>
                        <td align="left" rowspan="1" colspan="1">19.5</td>
                        <td align="left" rowspan="1" colspan="1">22.4</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Month 3</td>
                        <td align="left" rowspan="1" colspan="1">6.0</td>
                        <td align="left" rowspan="1" colspan="1">80</td>
                        <td align="left" rowspan="1" colspan="1">11.0</td>
                        <td align="left" rowspan="1" colspan="1">13</td>
                        <td align="left" rowspan="1" colspan="1">4.0</td>
                        <td align="left" rowspan="1" colspan="1">19.8</td>
                        <td align="left" rowspan="1" colspan="1">20.6</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Month 6</td>
                        <td align="left" rowspan="1" colspan="1">6.0</td>
                        <td align="left" rowspan="1" colspan="1">80</td>
                        <td align="left" rowspan="1" colspan="1">10.3</td>
                        <td align="left" rowspan="1" colspan="1">13</td>
                        <td align="left" rowspan="1" colspan="1">4.0</td>
                        <td align="left" rowspan="1" colspan="1">22.1</td>
                        <td align="left" rowspan="1" colspan="1">21.5</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Month 9</td>
                        <td align="left" rowspan="1" colspan="1">6.0</td>
                        <td align="left" rowspan="1" colspan="1">80</td>
                        <td align="left" rowspan="1" colspan="1">9.5</td>
                        <td align="left" rowspan="1" colspan="1">13</td>
                        <td align="left" rowspan="1" colspan="1">4.0</td>
                        <td align="left" rowspan="1" colspan="1">19.5</td>
                        <td align="left" rowspan="1" colspan="1">21.4</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Month 15</td>
                        <td align="left" rowspan="1" colspan="1">6.0</td>
                        <td align="left" rowspan="1" colspan="1">80</td>
                        <td align="left" rowspan="1" colspan="1">12.2</td>
                        <td align="left" rowspan="1" colspan="1">13</td>
                        <td align="left" rowspan="1" colspan="1">4.0</td>
                        <td align="left" rowspan="1" colspan="1">21.3</td>
                        <td align="left" rowspan="1" colspan="1">21.3</td>
                      </tr>
                    </tbody>
                  </table>
                  <table-wrap-foot id="acn351437-ntgp-0003">
                    <fn id="acn351437-note-0004">
                      <p>NA, not applicable; EDSS, Expanded Disability Status Scale; SNRS, Scripps Neurologic Rating Scale; T25‐FW, Timed 25‐Foot Walk; IPEC, Insituto de Pesquisa Clinica Evandro Chagas; AI, Ambulation Index; 9HPT, Nine‐Hole Peg Test.</p>
                    </fn>
                  </table-wrap-foot>
                  <permissions>
                    <copyright-holder>John Wiley &amp; Sons, Ltd</copyright-holder>
                  </permissions>
                </table-wrap>
              </sec>
              <sec id="acn351437-sec-0017">
                <title>HTLV‐1 PVL in HAM/TSP patients with raltegravir</title>
                <p>We analyzed HTLV‐1 PVL in PBMCs and CSF cells of the 16 HAM/TSP patients pre‐ and post‐administration of raltegravir. Before treatment, HTLV‐1 PVL was detected in the range of 0.79%–33.40% and 7.48%–58.53% in PBMC and CSF cells of the HAM/TSP patients, respectively (Table <xref rid="acn351437-tbl-0001" ref-type="table">1</xref>). As reported,<xref rid="acn351437-bib-0004" ref-type="bibr"><sup>4</sup></xref> HTLV‐1 PVL in CSF cells was much higher than the PVL in the PBMCs of each patient at pretreatment. Figure <xref rid="acn351437-fig-0002" ref-type="fig">2</xref> shows the group analysis of HTLV‐1 PVL in PBMCs and CSF cells (Fig. <xref rid="acn351437-fig-0002" ref-type="fig">2A and B</xref>, respectively) of the 16 HAM/TSP patients during the trial. There was no statistical change of HTLV‐1 PVL in the group analysis of either PBMCs or CSF cells during the trial, suggesting that HTLV‐1 PVL remained relatively stable in HAM/TSP patients after raltegravir treatment. However, analysis of individual patients showed a differential reduction of HTLV‐1 PVL in some patients (Table <xref rid="acn351437-tbl-0003" ref-type="table">3</xref>). Based on the percentage changes of HTLV‐1 PVL in the 6‐month treatment phase compared to the baseline, we classified HAM/TSP patients into three groups: patients with a decreased HTLV‐1 PVL into group 1, stable HTLV‐1 PVL into group 2, and patients with increased HTLV‐1 PVL into group 3 (Fig. <xref rid="acn351437-fig-0002" ref-type="fig">2C and D</xref>). The cut‐off value for change of HTLV‐1 PVL was determined as 12.19% based on the coefficient of variation of the HTLV‐1 PVL in PBMCs of 13 HAM/TSP patients observed in our natural history study (NINDS protocol 98‐N‐0047) ranging from 1 to 9 years. As shown in Figure <xref rid="acn351437-fig-0002" ref-type="fig">2C</xref>, eight HAM/TSP patients (group 1) demonstrated a reduction of HTLV‐1 PVL in PBMC at month 3 and/or month 6 of raltegravir treatment (Fig. <xref rid="acn351437-fig-0002" ref-type="fig">2C</xref>). Six patients in group 2 had stable HTLV‐1 PVL over this study period while only two HAM/TSP patients showed an increased HTLV‐1 PVL in PBMCs during treatment (group 3) (Fig. <xref rid="acn351437-fig-0002" ref-type="fig">2C</xref>). Analysis of HTLV‐1 PVL in CSF at month 6 of raltegravir treatment showed that 4 HAM/TSP patients trended toward a decrease in PVL (group 1) while seven HAM/TSP patients appeared relatively stable (group 2) (Fig. <xref rid="acn351437-fig-0002" ref-type="fig">2D</xref>). Five HAM/TSP patients showed increased HTLV‐1 PVL in the CSF (group 3) (Fig. <xref rid="acn351437-fig-0002" ref-type="fig">2D</xref>). Of note, some HAM/TSP patients also demonstrated a reduction of HTLV‐1 PVL in PBMC and/or CSF during the post‐treatment period. In this subset analysis, there was no correlation within any of these groups between CSF and PBMC proviral load (data not shown). Collectively, these results demonstrated that a downward trend in HTLV‐1 PVL, particularly in PBMCs, was observed in a subset of treated HAM/TSP patients even though group analysis showed no overall reduction of HTLV‐1 PVL in both PBMCs and CSF cells with raltegravir therapy.</p>
                <fig position="float" fig-type="Figure" id="acn351437-fig-0002">
                  <label>Figure 2</label>
                  <caption>
                    <p>HTLV‐1 PVL in HAM/TSP patients with raltegravir. (A) Group analysis of HTLV‐1 PVL in PBMCs of 16 HAM/TSP patients. Closed circles represent median of HTLV‐1 PVL and error bars represent range. (B) Group analysis of HTLV‐1 PVL in CSF cells of 16 HAM/TSP patients. Closed circles represent median of HTLV‐1 PVL and error bars represent range. (C) Classification of HAM/TSP patients into three groups based on change of HTLV‐1 PVL in PBMCs during the treatment. Group 1: Decreased HTLV‐1 PVL; Group 2: Stable (no significant change); Group 3: increased HTLV‐1 PVL. (D) Classification of HAM/TSP patients into three groups based on change of HTLV‐1 PVL in CSF cells during the treatment. Group 1: Decreased HTLV‐1 PVL; Group 2: No significant change; Group 3: increased HTLV‐1 PVL. Cut off value (12.19%) was determined based on coefficient of variation of PBMC HTLV‐1 PVL of 13 HAM/TSP patients with chronic infection in natural history of 1–9 years.</p>
                  </caption>
                  <graphic xlink:href="ACN3-8-1970-g003" position="anchor" id="jats-graphic-3"/>
                </fig>
                <table-wrap position="float" id="acn351437-tbl-0003" content-type="Table">
                  <label>Table 3</label>
                  <caption>
                    <p>HTLV‐1 PVL and immunological markers of HAM/TSP patients at baseline and post‐treatment of raltegravir.</p>
                  </caption>
                  <table frame="hsides" rules="groups">
                    <col style="border-right:solid 1px #000000" span="1"/>
                    <col style="border-right:solid 1px #000000" span="1"/>
                    <col style="border-right:solid 1px #000000" span="1"/>
                    <col style="border-right:solid 1px #000000" span="1"/>
                    <col style="border-right:solid 1px #000000" span="1"/>
                    <col style="border-right:solid 1px #000000" span="1"/>
                    <col style="border-right:solid 1px #000000" span="1"/>
                    <col style="border-right:solid 1px #000000" span="1"/>
                    <col style="border-right:solid 1px #000000" span="1"/>
                    <col style="border-right:solid 1px #000000" span="1"/>
                    <col style="border-right:solid 1px #000000" span="1"/>
                    <thead valign="bottom">
                      <tr style="border-bottom:solid 1px #000000">
                        <th align="left" rowspan="2" valign="bottom" colspan="1">Patient No.</th>
                        <th align="center" rowspan="2" valign="bottom" colspan="1">Time course</th>
                        <th align="center" colspan="2" style="border-bottom:solid 1px #000000" valign="bottom" rowspan="1">HTLV‐1 PVL (%)</th>
                        <th align="center" colspan="2" style="border-bottom:solid 1px #000000" valign="bottom" rowspan="1">CD4<sup>+</sup>CD25<sup>+</sup> T cells (%)</th>
                        <th align="center" colspan="2" style="border-bottom:solid 1px #000000" valign="bottom" rowspan="1">CD8<sup>+</sup>CD25<sup>+</sup> T cells (%)</th>
                        <th align="center" colspan="2" style="border-bottom:solid 1px #000000" valign="bottom" rowspan="1">CD8<sup>+</sup>CD122<sup>+</sup> T cells (%)</th>
                        <th align="center" style="border-bottom:solid 1px #000000" valign="bottom" rowspan="1" colspan="1">Antibody secreting B cells (%)</th>
                      </tr>
                      <tr style="border-bottom:solid 1px #000000">
                        <th align="center" valign="bottom" rowspan="1" colspan="1">PBMC<xref rid="acn351437-note-0006" ref-type="table-fn"><sup>1</sup></xref>
</th>
                        <th align="center" valign="bottom" rowspan="1" colspan="1">CSF</th>
                        <th align="center" valign="bottom" rowspan="1" colspan="1">PBMC<xref rid="acn351437-note-0006" ref-type="table-fn"><sup>1</sup></xref>
</th>
                        <th align="center" valign="bottom" rowspan="1" colspan="1">CSF</th>
                        <th align="center" valign="bottom" rowspan="1" colspan="1">PBMC<xref rid="acn351437-note-0006" ref-type="table-fn"><sup>1</sup></xref>
</th>
                        <th align="center" valign="bottom" rowspan="1" colspan="1">CSF</th>
                        <th align="center" valign="bottom" rowspan="1" colspan="1">PBMC<xref rid="acn351437-note-0006" ref-type="table-fn"><sup>1</sup></xref>
</th>
                        <th align="center" valign="bottom" rowspan="1" colspan="1">CSF</th>
                        <th align="center" valign="bottom" rowspan="1" colspan="1">CSF</th>
                      </tr>
                    </thead>
                    <tbody>
                      <tr>
                        <td align="left" rowspan="3" colspan="1">HAM #1</td>
                        <td align="left" rowspan="1" colspan="1">Baseline</td>
                        <td align="left" rowspan="1" colspan="1">20.50</td>
                        <td align="left" rowspan="1" colspan="1">45.06</td>
                        <td align="left" rowspan="1" colspan="1">16.25</td>
                        <td align="left" rowspan="1" colspan="1">12.20</td>
                        <td align="left" rowspan="1" colspan="1">3.47</td>
                        <td align="left" rowspan="1" colspan="1">1.64</td>
                        <td align="left" rowspan="1" colspan="1">57.90</td>
                        <td align="left" rowspan="1" colspan="1">63.20</td>
                        <td align="left" rowspan="1" colspan="1">5.43</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Month 6</td>
                        <td align="left" rowspan="1" colspan="1">17.30</td>
                        <td align="left" rowspan="1" colspan="1">48.61</td>
                        <td align="left" rowspan="1" colspan="1">16.60</td>
                        <td align="left" rowspan="1" colspan="1">12.90</td>
                        <td align="left" rowspan="1" colspan="1">5.60</td>
                        <td align="left" rowspan="1" colspan="1">1.32</td>
                        <td align="left" rowspan="1" colspan="1">30.60</td>
                        <td align="left" rowspan="1" colspan="1">67.20</td>
                        <td align="left" rowspan="1" colspan="1">6.20</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Month 15</td>
                        <td align="left" rowspan="1" colspan="1">21.37</td>
                        <td align="left" rowspan="1" colspan="1">39.14</td>
                        <td align="left" rowspan="1" colspan="1">7.96</td>
                        <td align="left" rowspan="1" colspan="1">2.80</td>
                        <td align="left" rowspan="1" colspan="1">2.67</td>
                        <td align="left" rowspan="1" colspan="1">0.40</td>
                        <td align="left" rowspan="1" colspan="1">60.00</td>
                        <td align="left" rowspan="1" colspan="1">59.00</td>
                        <td align="left" rowspan="1" colspan="1">0.81</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="3" colspan="1">HAM #2</td>
                        <td align="left" rowspan="1" colspan="1">Baseline</td>
                        <td align="left" rowspan="1" colspan="1">15.34</td>
                        <td align="left" rowspan="1" colspan="1">25.84</td>
                        <td align="left" rowspan="1" colspan="1">5.14</td>
                        <td align="left" rowspan="1" colspan="1">10.10</td>
                        <td align="left" rowspan="1" colspan="1">0.64</td>
                        <td align="left" rowspan="1" colspan="1">1.67</td>
                        <td align="left" rowspan="1" colspan="1">37.05</td>
                        <td align="left" rowspan="1" colspan="1">ND</td>
                        <td align="left" rowspan="1" colspan="1">8.57</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Month 6</td>
                        <td align="left" rowspan="1" colspan="1">14.58</td>
                        <td align="left" rowspan="1" colspan="1">22.00</td>
                        <td align="left" rowspan="1" colspan="1">6.31</td>
                        <td align="left" rowspan="1" colspan="1">8.76</td>
                        <td align="left" rowspan="1" colspan="1">0.86</td>
                        <td align="left" rowspan="1" colspan="1">0.98</td>
                        <td align="left" rowspan="1" colspan="1">29.30</td>
                        <td align="left" rowspan="1" colspan="1">77.60</td>
                        <td align="left" rowspan="1" colspan="1">9.09</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Month 15</td>
                        <td align="left" rowspan="1" colspan="1">13.04</td>
                        <td align="left" rowspan="1" colspan="1">19.32</td>
                        <td align="left" rowspan="1" colspan="1">7.68</td>
                        <td align="left" rowspan="1" colspan="1">5.68</td>
                        <td align="left" rowspan="1" colspan="1">0.40</td>
                        <td align="left" rowspan="1" colspan="1">0.94</td>
                        <td align="left" rowspan="1" colspan="1">27.10</td>
                        <td align="left" rowspan="1" colspan="1">80.70</td>
                        <td align="left" rowspan="1" colspan="1">5.13</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="3" colspan="1">HAM #3</td>
                        <td align="left" rowspan="1" colspan="1">Baseline</td>
                        <td align="left" rowspan="1" colspan="1">10.92</td>
                        <td align="left" rowspan="1" colspan="1">50.95</td>
                        <td align="left" rowspan="1" colspan="1">11.55</td>
                        <td align="left" rowspan="1" colspan="1">27.40</td>
                        <td align="left" rowspan="1" colspan="1">0.76</td>
                        <td align="left" rowspan="1" colspan="1">2.41</td>
                        <td align="left" rowspan="1" colspan="1">37.70</td>
                        <td align="left" rowspan="1" colspan="1">88.80</td>
                        <td align="left" rowspan="1" colspan="1">16.60</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Month 6</td>
                        <td align="left" rowspan="1" colspan="1">13.21</td>
                        <td align="left" rowspan="1" colspan="1">56.24</td>
                        <td align="left" rowspan="1" colspan="1">13.20</td>
                        <td align="left" rowspan="1" colspan="1">31.00</td>
                        <td align="left" rowspan="1" colspan="1">0.89</td>
                        <td align="left" rowspan="1" colspan="1">5.14</td>
                        <td align="left" rowspan="1" colspan="1">41.60</td>
                        <td align="left" rowspan="1" colspan="1">94.00</td>
                        <td align="left" rowspan="1" colspan="1">10.00</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Month 15</td>
                        <td align="left" rowspan="1" colspan="1">13.54</td>
                        <td align="left" rowspan="1" colspan="1">54.66</td>
                        <td align="left" rowspan="1" colspan="1">6.44</td>
                        <td align="left" rowspan="1" colspan="1">19.90</td>
                        <td align="left" rowspan="1" colspan="1">0.77</td>
                        <td align="left" rowspan="1" colspan="1">7.40</td>
                        <td align="left" rowspan="1" colspan="1">26.20</td>
                        <td align="left" rowspan="1" colspan="1">89.10</td>
                        <td align="left" rowspan="1" colspan="1">4.79</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="3" colspan="1">HAM #4</td>
                        <td align="left" rowspan="1" colspan="1">Baseline</td>
                        <td align="left" rowspan="1" colspan="1">10.63</td>
                        <td align="left" rowspan="1" colspan="1">29.73</td>
                        <td align="left" rowspan="1" colspan="1">3.97</td>
                        <td align="left" rowspan="1" colspan="1">5.07</td>
                        <td align="left" rowspan="1" colspan="1">0.78</td>
                        <td align="left" rowspan="1" colspan="1">0.23</td>
                        <td align="left" rowspan="1" colspan="1">48.45</td>
                        <td align="left" rowspan="1" colspan="1">74.90</td>
                        <td align="left" rowspan="1" colspan="1">(‐)</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Month 6</td>
                        <td align="left" rowspan="1" colspan="1">10.70</td>
                        <td align="left" rowspan="1" colspan="1">27.40</td>
                        <td align="left" rowspan="1" colspan="1">8.63</td>
                        <td align="left" rowspan="1" colspan="1">6.24</td>
                        <td align="left" rowspan="1" colspan="1">0.87</td>
                        <td align="left" rowspan="1" colspan="1">0.54</td>
                        <td align="left" rowspan="1" colspan="1">53.50</td>
                        <td align="left" rowspan="1" colspan="1">81.80</td>
                        <td align="left" rowspan="1" colspan="1">(‐)</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Month 15</td>
                        <td align="left" rowspan="1" colspan="1">13.69</td>
                        <td align="left" rowspan="1" colspan="1">30.07</td>
                        <td align="left" rowspan="1" colspan="1">4.09</td>
                        <td align="left" rowspan="1" colspan="1">3.76</td>
                        <td align="left" rowspan="1" colspan="1">0.43</td>
                        <td align="left" rowspan="1" colspan="1">0.57</td>
                        <td align="left" rowspan="1" colspan="1">30.60</td>
                        <td align="left" rowspan="1" colspan="1">68.00</td>
                        <td align="left" rowspan="1" colspan="1">(‐)</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="3" colspan="1">HAM #5</td>
                        <td align="left" rowspan="1" colspan="1">Baseline</td>
                        <td align="left" rowspan="1" colspan="1">18.37</td>
                        <td align="left" rowspan="1" colspan="1">25.70</td>
                        <td align="left" rowspan="1" colspan="1">10.70</td>
                        <td align="left" rowspan="1" colspan="1">8.09</td>
                        <td align="left" rowspan="1" colspan="1">5.75</td>
                        <td align="left" rowspan="1" colspan="1">0.72</td>
                        <td align="left" rowspan="1" colspan="1">38.35</td>
                        <td align="left" rowspan="1" colspan="1">62.20</td>
                        <td align="left" rowspan="1" colspan="1">1.79</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Month 6</td>
                        <td align="left" rowspan="1" colspan="1">14.87</td>
                        <td align="left" rowspan="1" colspan="1">31.95</td>
                        <td align="left" rowspan="1" colspan="1">12.30</td>
                        <td align="left" rowspan="1" colspan="1">7.18</td>
                        <td align="left" rowspan="1" colspan="1">4.39</td>
                        <td align="left" rowspan="1" colspan="1">1.20</td>
                        <td align="left" rowspan="1" colspan="1">27.60</td>
                        <td align="left" rowspan="1" colspan="1">76.30</td>
                        <td align="left" rowspan="1" colspan="1">0.00</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Month 15</td>
                        <td align="left" rowspan="1" colspan="1">11.71</td>
                        <td align="left" rowspan="1" colspan="1">ND</td>
                        <td align="left" rowspan="1" colspan="1">2.48</td>
                        <td align="left" rowspan="1" colspan="1">ND</td>
                        <td align="left" rowspan="1" colspan="1">0.63</td>
                        <td align="left" rowspan="1" colspan="1">ND</td>
                        <td align="left" rowspan="1" colspan="1">21.70</td>
                        <td align="left" rowspan="1" colspan="1">ND</td>
                        <td align="left" rowspan="1" colspan="1">ND</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="3" colspan="1">HAM #7</td>
                        <td align="left" rowspan="1" colspan="1">Baseline</td>
                        <td align="left" rowspan="1" colspan="1">16.60</td>
                        <td align="left" rowspan="1" colspan="1">40.44</td>
                        <td align="left" rowspan="1" colspan="1">7.01</td>
                        <td align="left" rowspan="1" colspan="1">7.85</td>
                        <td align="left" rowspan="1" colspan="1">1.19</td>
                        <td align="left" rowspan="1" colspan="1">2.10</td>
                        <td align="left" rowspan="1" colspan="1">46.25</td>
                        <td align="left" rowspan="1" colspan="1">89.60</td>
                        <td align="left" rowspan="1" colspan="1">1.56</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Month 6</td>
                        <td align="left" rowspan="1" colspan="1">10.81</td>
                        <td align="left" rowspan="1" colspan="1">34.27</td>
                        <td align="left" rowspan="1" colspan="1">7.76</td>
                        <td align="left" rowspan="1" colspan="1">7.21</td>
                        <td align="left" rowspan="1" colspan="1">1.40</td>
                        <td align="left" rowspan="1" colspan="1">1.56</td>
                        <td align="left" rowspan="1" colspan="1">39.80</td>
                        <td align="left" rowspan="1" colspan="1">81.00</td>
                        <td align="left" rowspan="1" colspan="1">0.00</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Month 15</td>
                        <td align="left" rowspan="1" colspan="1">ND</td>
                        <td align="left" rowspan="1" colspan="1">ND</td>
                        <td align="left" rowspan="1" colspan="1">ND</td>
                        <td align="left" rowspan="1" colspan="1">ND</td>
                        <td align="left" rowspan="1" colspan="1">ND</td>
                        <td align="left" rowspan="1" colspan="1">ND</td>
                        <td align="left" rowspan="1" colspan="1">ND</td>
                        <td align="left" rowspan="1" colspan="1">ND</td>
                        <td align="left" rowspan="1" colspan="1">ND</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="3" colspan="1">HAM #8</td>
                        <td align="left" rowspan="1" colspan="1">Baseline</td>
                        <td align="left" rowspan="1" colspan="1">0.79</td>
                        <td align="left" rowspan="1" colspan="1">7.48</td>
                        <td align="left" rowspan="1" colspan="1">2.13</td>
                        <td align="left" rowspan="1" colspan="1">2.25</td>
                        <td align="left" rowspan="1" colspan="1">0.22</td>
                        <td align="left" rowspan="1" colspan="1">0.66</td>
                        <td align="left" rowspan="1" colspan="1">34.15</td>
                        <td align="left" rowspan="1" colspan="1">57.20</td>
                        <td align="left" rowspan="1" colspan="1">1.67</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Month 6</td>
                        <td align="left" rowspan="1" colspan="1">0.93</td>
                        <td align="left" rowspan="1" colspan="1">7.76</td>
                        <td align="left" rowspan="1" colspan="1">1.09</td>
                        <td align="left" rowspan="1" colspan="1">2.01</td>
                        <td align="left" rowspan="1" colspan="1">0.09</td>
                        <td align="left" rowspan="1" colspan="1">0.46</td>
                        <td align="left" rowspan="1" colspan="1">28.30</td>
                        <td align="left" rowspan="1" colspan="1">55.80</td>
                        <td align="left" rowspan="1" colspan="1">2.17</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Month 15</td>
                        <td align="left" rowspan="1" colspan="1">0.72</td>
                        <td align="left" rowspan="1" colspan="1">7.47</td>
                        <td align="left" rowspan="1" colspan="1">1.14</td>
                        <td align="left" rowspan="1" colspan="1">2.98</td>
                        <td align="left" rowspan="1" colspan="1">0.17</td>
                        <td align="left" rowspan="1" colspan="1">0.90</td>
                        <td align="left" rowspan="1" colspan="1">26.00</td>
                        <td align="left" rowspan="1" colspan="1">54.20</td>
                        <td align="left" rowspan="1" colspan="1">0.00</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="3" colspan="1">HAM #9</td>
                        <td align="left" rowspan="1" colspan="1">Baseline</td>
                        <td align="left" rowspan="1" colspan="1">11.57</td>
                        <td align="left" rowspan="1" colspan="1">20.36</td>
                        <td align="left" rowspan="1" colspan="1">4.52</td>
                        <td align="left" rowspan="1" colspan="1">5.14</td>
                        <td align="left" rowspan="1" colspan="1">0.65</td>
                        <td align="left" rowspan="1" colspan="1">0.14</td>
                        <td align="left" rowspan="1" colspan="1">39.00</td>
                        <td align="left" rowspan="1" colspan="1">71.70</td>
                        <td align="left" rowspan="1" colspan="1">0.00</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Month 6</td>
                        <td align="left" rowspan="1" colspan="1">10.42</td>
                        <td align="left" rowspan="1" colspan="1">23.69</td>
                        <td align="left" rowspan="1" colspan="1">2.73</td>
                        <td align="left" rowspan="1" colspan="1">4.57</td>
                        <td align="left" rowspan="1" colspan="1">0.49</td>
                        <td align="left" rowspan="1" colspan="1">0.57</td>
                        <td align="left" rowspan="1" colspan="1">28.10</td>
                        <td align="left" rowspan="1" colspan="1">65.90</td>
                        <td align="left" rowspan="1" colspan="1">0.00</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Month 15</td>
                        <td align="left" rowspan="1" colspan="1">10.22</td>
                        <td align="left" rowspan="1" colspan="1">28.89</td>
                        <td align="left" rowspan="1" colspan="1">2.34</td>
                        <td align="left" rowspan="1" colspan="1">3.31</td>
                        <td align="left" rowspan="1" colspan="1">0.34</td>
                        <td align="left" rowspan="1" colspan="1">0.58</td>
                        <td align="left" rowspan="1" colspan="1">32.80</td>
                        <td align="left" rowspan="1" colspan="1">63.50</td>
                        <td align="left" rowspan="1" colspan="1">(‐)</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="3" colspan="1">HAM #10</td>
                        <td align="left" rowspan="1" colspan="1">Baseline</td>
                        <td align="left" rowspan="1" colspan="1">13.72</td>
                        <td align="left" rowspan="1" colspan="1">51.68</td>
                        <td align="left" rowspan="1" colspan="1">3.90</td>
                        <td align="left" rowspan="1" colspan="1">1.67</td>
                        <td align="left" rowspan="1" colspan="1">0.21</td>
                        <td align="left" rowspan="1" colspan="1">0.45</td>
                        <td align="left" rowspan="1" colspan="1">34.55</td>
                        <td align="left" rowspan="1" colspan="1">60.00</td>
                        <td align="left" rowspan="1" colspan="1">0.92</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Month 6</td>
                        <td align="left" rowspan="1" colspan="1">14.74</td>
                        <td align="left" rowspan="1" colspan="1">38.19</td>
                        <td align="left" rowspan="1" colspan="1">4.37</td>
                        <td align="left" rowspan="1" colspan="1">5.84</td>
                        <td align="left" rowspan="1" colspan="1">0.31</td>
                        <td align="left" rowspan="1" colspan="1">0.62</td>
                        <td align="left" rowspan="1" colspan="1">41.60</td>
                        <td align="left" rowspan="1" colspan="1">58.10</td>
                        <td align="left" rowspan="1" colspan="1">0.00</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Month 15</td>
                        <td align="left" rowspan="1" colspan="1">10.62</td>
                        <td align="left" rowspan="1" colspan="1">4.10</td>
                        <td align="left" rowspan="1" colspan="1">2.53</td>
                        <td align="left" rowspan="1" colspan="1">3.74</td>
                        <td align="left" rowspan="1" colspan="1">0.17</td>
                        <td align="left" rowspan="1" colspan="1">0.55</td>
                        <td align="left" rowspan="1" colspan="1">24.60</td>
                        <td align="left" rowspan="1" colspan="1">60.20</td>
                        <td align="left" rowspan="1" colspan="1">(‐)</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="3" colspan="1">HAM #12</td>
                        <td align="left" rowspan="1" colspan="1">Baseline</td>
                        <td align="left" rowspan="1" colspan="1">12.76</td>
                        <td align="left" rowspan="1" colspan="1">15.55</td>
                        <td align="left" rowspan="1" colspan="1">4.44</td>
                        <td align="left" rowspan="1" colspan="1">3.52</td>
                        <td align="left" rowspan="1" colspan="1">0.64</td>
                        <td align="left" rowspan="1" colspan="1">0.26</td>
                        <td align="left" rowspan="1" colspan="1">45.85</td>
                        <td align="left" rowspan="1" colspan="1">58.00</td>
                        <td align="left" rowspan="1" colspan="1">1.64</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Month 6</td>
                        <td align="left" rowspan="1" colspan="1">11.36</td>
                        <td align="left" rowspan="1" colspan="1">22.36</td>
                        <td align="left" rowspan="1" colspan="1">4.17</td>
                        <td align="left" rowspan="1" colspan="1">3.21</td>
                        <td align="left" rowspan="1" colspan="1">0.83</td>
                        <td align="left" rowspan="1" colspan="1">0.29</td>
                        <td align="left" rowspan="1" colspan="1">57.40</td>
                        <td align="left" rowspan="1" colspan="1">64.10</td>
                        <td align="left" rowspan="1" colspan="1">0.00</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Month 15</td>
                        <td align="left" rowspan="1" colspan="1">10.83</td>
                        <td align="left" rowspan="1" colspan="1">37.71</td>
                        <td align="left" rowspan="1" colspan="1">1.25</td>
                        <td align="left" rowspan="1" colspan="1">1.83</td>
                        <td align="left" rowspan="1" colspan="1">0.18</td>
                        <td align="left" rowspan="1" colspan="1">0.87</td>
                        <td align="left" rowspan="1" colspan="1">40.20</td>
                        <td align="left" rowspan="1" colspan="1">52.10</td>
                        <td align="left" rowspan="1" colspan="1">1.33</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="3" colspan="1">HAM #13</td>
                        <td align="left" rowspan="1" colspan="1">Baseline</td>
                        <td align="left" rowspan="1" colspan="1">20.73</td>
                        <td align="left" rowspan="1" colspan="1">23.17</td>
                        <td align="left" rowspan="1" colspan="1">16.59</td>
                        <td align="left" rowspan="1" colspan="1">13.70</td>
                        <td align="left" rowspan="1" colspan="1">2.78</td>
                        <td align="left" rowspan="1" colspan="1">3.11</td>
                        <td align="left" rowspan="1" colspan="1">49.10</td>
                        <td align="left" rowspan="1" colspan="1">82.00</td>
                        <td align="left" rowspan="1" colspan="1">8.33</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Month 6</td>
                        <td align="left" rowspan="1" colspan="1">26.35</td>
                        <td align="left" rowspan="1" colspan="1">22.02</td>
                        <td align="left" rowspan="1" colspan="1">20.80</td>
                        <td align="left" rowspan="1" colspan="1">6.33</td>
                        <td align="left" rowspan="1" colspan="1">3.48</td>
                        <td align="left" rowspan="1" colspan="1">0.77</td>
                        <td align="left" rowspan="1" colspan="1">47.90</td>
                        <td align="left" rowspan="1" colspan="1">55.00</td>
                        <td align="left" rowspan="1" colspan="1">0.00</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Month 15</td>
                        <td align="left" rowspan="1" colspan="1">10.90</td>
                        <td align="left" rowspan="1" colspan="1">25.33</td>
                        <td align="left" rowspan="1" colspan="1">10.10</td>
                        <td align="left" rowspan="1" colspan="1">9.72</td>
                        <td align="left" rowspan="1" colspan="1">0.64</td>
                        <td align="left" rowspan="1" colspan="1">1.42</td>
                        <td align="left" rowspan="1" colspan="1">46.80</td>
                        <td align="left" rowspan="1" colspan="1">52.00</td>
                        <td align="left" rowspan="1" colspan="1">(‐)</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="3" colspan="1">HAM #14</td>
                        <td align="left" rowspan="1" colspan="1">Baseline</td>
                        <td align="left" rowspan="1" colspan="1">33.40</td>
                        <td align="left" rowspan="1" colspan="1">58.53</td>
                        <td align="left" rowspan="1" colspan="1">15.20</td>
                        <td align="left" rowspan="1" colspan="1">18.30</td>
                        <td align="left" rowspan="1" colspan="1">2.37</td>
                        <td align="left" rowspan="1" colspan="1">4.74</td>
                        <td align="left" rowspan="1" colspan="1">45.40</td>
                        <td align="left" rowspan="1" colspan="1">81.30</td>
                        <td align="left" rowspan="1" colspan="1">8.33</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Month 6</td>
                        <td align="left" rowspan="1" colspan="1">29.57</td>
                        <td align="left" rowspan="1" colspan="1">68.10</td>
                        <td align="left" rowspan="1" colspan="1">13.30</td>
                        <td align="left" rowspan="1" colspan="1">4.74</td>
                        <td align="left" rowspan="1" colspan="1">2.42</td>
                        <td align="left" rowspan="1" colspan="1">0.88</td>
                        <td align="left" rowspan="1" colspan="1">40.20</td>
                        <td align="left" rowspan="1" colspan="1">60.80</td>
                        <td align="left" rowspan="1" colspan="1">0.00</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Month 15</td>
                        <td align="left" rowspan="1" colspan="1">32.21</td>
                        <td align="left" rowspan="1" colspan="1">65.40</td>
                        <td align="left" rowspan="1" colspan="1">13.70</td>
                        <td align="left" rowspan="1" colspan="1">12.20</td>
                        <td align="left" rowspan="1" colspan="1">1.95</td>
                        <td align="left" rowspan="1" colspan="1">3.11</td>
                        <td align="left" rowspan="1" colspan="1">52.20</td>
                        <td align="left" rowspan="1" colspan="1">61.20</td>
                        <td align="left" rowspan="1" colspan="1">0.00</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="3" colspan="1">HAM #15</td>
                        <td align="left" rowspan="1" colspan="1">Baseline</td>
                        <td align="left" rowspan="1" colspan="1">18.84</td>
                        <td align="left" rowspan="1" colspan="1">23.00</td>
                        <td align="left" rowspan="1" colspan="1">7.93</td>
                        <td align="left" rowspan="1" colspan="1">14.10</td>
                        <td align="left" rowspan="1" colspan="1">1.06</td>
                        <td align="left" rowspan="1" colspan="1">2.41</td>
                        <td align="left" rowspan="1" colspan="1">51.70</td>
                        <td align="left" rowspan="1" colspan="1">84.80</td>
                        <td align="left" rowspan="1" colspan="1">8.70</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Month 6</td>
                        <td align="left" rowspan="1" colspan="1">17.85</td>
                        <td align="left" rowspan="1" colspan="1">18.64</td>
                        <td align="left" rowspan="1" colspan="1">6.98</td>
                        <td align="left" rowspan="1" colspan="1">2.09</td>
                        <td align="left" rowspan="1" colspan="1">0.95</td>
                        <td align="left" rowspan="1" colspan="1">0.42</td>
                        <td align="left" rowspan="1" colspan="1">42.00</td>
                        <td align="left" rowspan="1" colspan="1">55.60</td>
                        <td align="left" rowspan="1" colspan="1">0.00</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Month 15</td>
                        <td align="left" rowspan="1" colspan="1">33.74</td>
                        <td align="left" rowspan="1" colspan="1">37.80</td>
                        <td align="left" rowspan="1" colspan="1">3.06</td>
                        <td align="left" rowspan="1" colspan="1">9.67</td>
                        <td align="left" rowspan="1" colspan="1">0.36</td>
                        <td align="left" rowspan="1" colspan="1">1.36</td>
                        <td align="left" rowspan="1" colspan="1">38.10</td>
                        <td align="left" rowspan="1" colspan="1">57.10</td>
                        <td align="left" rowspan="1" colspan="1">0.00</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="3" colspan="1">HAM #16</td>
                        <td align="left" rowspan="1" colspan="1">Baseline</td>
                        <td align="left" rowspan="1" colspan="1">10.11</td>
                        <td align="left" rowspan="1" colspan="1">32.13</td>
                        <td align="left" rowspan="1" colspan="1">7.64</td>
                        <td align="left" rowspan="1" colspan="1">14.60</td>
                        <td align="left" rowspan="1" colspan="1">0.42</td>
                        <td align="left" rowspan="1" colspan="1">2.72</td>
                        <td align="left" rowspan="1" colspan="1">32.70</td>
                        <td align="left" rowspan="1" colspan="1">69.00</td>
                        <td align="left" rowspan="1" colspan="1">4.00</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Month 6</td>
                        <td align="left" rowspan="1" colspan="1">9.31</td>
                        <td align="left" rowspan="1" colspan="1">30.43</td>
                        <td align="left" rowspan="1" colspan="1">5.17</td>
                        <td align="left" rowspan="1" colspan="1">7.75</td>
                        <td align="left" rowspan="1" colspan="1">0.40</td>
                        <td align="left" rowspan="1" colspan="1">0.82</td>
                        <td align="left" rowspan="1" colspan="1">35.50</td>
                        <td align="left" rowspan="1" colspan="1">53.90</td>
                        <td align="left" rowspan="1" colspan="1">11.50</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Month 15</td>
                        <td align="left" rowspan="1" colspan="1">7.50</td>
                        <td align="left" rowspan="1" colspan="1">37.16</td>
                        <td align="left" rowspan="1" colspan="1">4.95</td>
                        <td align="left" rowspan="1" colspan="1">9.07</td>
                        <td align="left" rowspan="1" colspan="1">0.80</td>
                        <td align="left" rowspan="1" colspan="1">1.74</td>
                        <td align="left" rowspan="1" colspan="1">31.90</td>
                        <td align="left" rowspan="1" colspan="1">45.90</td>
                        <td align="left" rowspan="1" colspan="1">5.41</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="3" colspan="1">HAM #17</td>
                        <td align="left" rowspan="1" colspan="1">Baseline</td>
                        <td align="left" rowspan="1" colspan="1">27.75</td>
                        <td align="left" rowspan="1" colspan="1">34.42</td>
                        <td align="left" rowspan="1" colspan="1">5.05</td>
                        <td align="left" rowspan="1" colspan="1">1.84</td>
                        <td align="left" rowspan="1" colspan="1">0.73</td>
                        <td align="left" rowspan="1" colspan="1">0.41</td>
                        <td align="left" rowspan="1" colspan="1">61.60</td>
                        <td align="left" rowspan="1" colspan="1">83.60</td>
                        <td align="left" rowspan="1" colspan="1">1.39</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Month 6</td>
                        <td align="left" rowspan="1" colspan="1">25.00</td>
                        <td align="left" rowspan="1" colspan="1">59.88</td>
                        <td align="left" rowspan="1" colspan="1">5.83</td>
                        <td align="left" rowspan="1" colspan="1">13.40</td>
                        <td align="left" rowspan="1" colspan="1">0.69</td>
                        <td align="left" rowspan="1" colspan="1">1.90</td>
                        <td align="left" rowspan="1" colspan="1">49.00</td>
                        <td align="left" rowspan="1" colspan="1">92.50</td>
                        <td align="left" rowspan="1" colspan="1">3.28</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Month 15</td>
                        <td align="left" rowspan="1" colspan="1">29.72</td>
                        <td align="left" rowspan="1" colspan="1">49.75</td>
                        <td align="left" rowspan="1" colspan="1">2.70</td>
                        <td align="left" rowspan="1" colspan="1">6.18</td>
                        <td align="left" rowspan="1" colspan="1">0.22</td>
                        <td align="left" rowspan="1" colspan="1">2.44</td>
                        <td align="left" rowspan="1" colspan="1">51.30</td>
                        <td align="left" rowspan="1" colspan="1">60.20</td>
                        <td align="left" rowspan="1" colspan="1">2.38</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="3" colspan="1">HAM #18</td>
                        <td align="left" rowspan="1" colspan="1">Baseline</td>
                        <td align="left" rowspan="1" colspan="1">17.07</td>
                        <td align="left" rowspan="1" colspan="1">27.34</td>
                        <td align="left" rowspan="1" colspan="1">6.12</td>
                        <td align="left" rowspan="1" colspan="1">12.50</td>
                        <td align="left" rowspan="1" colspan="1">0.44</td>
                        <td align="left" rowspan="1" colspan="1">2.35</td>
                        <td align="left" rowspan="1" colspan="1">38.95</td>
                        <td align="left" rowspan="1" colspan="1">66.90</td>
                        <td align="left" rowspan="1" colspan="1">4.17</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Month 6</td>
                        <td align="left" rowspan="1" colspan="1">18.77</td>
                        <td align="left" rowspan="1" colspan="1">27.27</td>
                        <td align="left" rowspan="1" colspan="1">11.60</td>
                        <td align="left" rowspan="1" colspan="1">13.10</td>
                        <td align="left" rowspan="1" colspan="1">0.98</td>
                        <td align="left" rowspan="1" colspan="1">1.57</td>
                        <td align="left" rowspan="1" colspan="1">62.00</td>
                        <td align="left" rowspan="1" colspan="1">89.30</td>
                        <td align="left" rowspan="1" colspan="1">2.15</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Month 15</td>
                        <td align="left" rowspan="1" colspan="1">19.20</td>
                        <td align="left" rowspan="1" colspan="1">49.03</td>
                        <td align="left" rowspan="1" colspan="1">12.30</td>
                        <td align="left" rowspan="1" colspan="1">16.30</td>
                        <td align="left" rowspan="1" colspan="1">0.77</td>
                        <td align="left" rowspan="1" colspan="1">2.38</td>
                        <td align="left" rowspan="1" colspan="1">39.90</td>
                        <td align="left" rowspan="1" colspan="1">75.40</td>
                        <td align="left" rowspan="1" colspan="1">0.00</td>
                      </tr>
                    </tbody>
                  </table>
                  <table-wrap-foot id="acn351437-ntgp-0004">
                    <fn id="acn351437-note-0005">
                      <p>(‐): It was not able to analyze due to low B cell number. ND, Not done.</p>
                    </fn>
                    <fn id="acn351437-note-0006">
                      <label>
                        <sup>1</sup>
                      </label>
                      <p>Baseline: Average of two baselines (month 0 and up to 3 months before the treatment).</p>
                    </fn>
                  </table-wrap-foot>
                  <permissions>
                    <copyright-holder>John Wiley &amp; Sons, Ltd</copyright-holder>
                  </permissions>
                </table-wrap>
              </sec>
              <sec id="acn351437-sec-0018">
                <title>HTLV‐1 mRNA expression in PBMC of HAM/TSP patients with raltegravir</title>
                <p>Two HTLV‐1 genes, <italic toggle="yes">tax</italic> and <italic toggle="yes">HBZ</italic>, have been shown to play important roles in the pathogenesis of HAM/TSP.<xref rid="acn351437-bib-0024" ref-type="bibr"><sup>24</sup></xref> To determine if raltegravir affected HTLV‐1 mRNA expression in HAM/TSP patients, we examined and compared HTLV‐1 mRNA expressions, <italic toggle="yes">tax</italic> and <italic toggle="yes">HBZ</italic>, in PBMCs of HAM/TSP patients at pretreatment, at month 6, and month 15 of raltegravir treatment. Although HTLV‐1 <italic toggle="yes">tax</italic> mRNA is rarely detectable directly in fresh PBMCs of HTLV‐1‐infected individuals, HAM/TSP patients are known to have spontaneously increase <italic toggle="yes">tax</italic> mRNA expression in PBMCs after ex vivo culture without any exogenous stimulators.<xref rid="acn351437-bib-0006" ref-type="bibr"><sup>6</sup></xref> Interestingly, group analysis of <italic toggle="yes">tax</italic> mRNA expression after such ex vivo culture showed a significant inhibition in PBMCs of HAM/TSP patients after treatment that was sustained at the 15 month time point (Fig. <xref rid="acn351437-fig-0003" ref-type="fig">3A</xref>). This inhibition appeared specific for HTLV‐1 <italic toggle="yes">tax</italic> mRNA since no such inhibition of the HTLV‐1 <italic toggle="yes">HBZ</italic> mRNA was seen. Unlike <italic toggle="yes">tax</italic> mRNA, <italic toggle="yes">HBZ</italic> mRNA is ubiquitously expressed in HTLV‐1‐infected cells and in PBMCs of HAM/TSP patients.<xref rid="acn351437-bib-0025" ref-type="bibr"><sup>25</sup></xref>, <xref rid="acn351437-bib-0026" ref-type="bibr"><sup>26</sup></xref> Consistent with these previous studies, the expression of <italic toggle="yes">HBZ</italic> mRNA was detected in uncultured PBMCs of all the HAM/TSP patients (Fig. <xref rid="acn351437-fig-0003" ref-type="fig">3B</xref>). However, in contrast to <italic toggle="yes">tax</italic> mRNA expression (Fig. <xref rid="acn351437-fig-0003" ref-type="fig">3A</xref>), group analysis of <italic toggle="yes">HBZ</italic> mRNA expression did not show any significant change in fresh, uncultured PBMCs of HAM/TSP patients after treatment with raltegravir (Fig. <xref rid="acn351437-fig-0003" ref-type="fig">3B</xref>). Consistent with previous reports,<xref rid="acn351437-bib-0006" ref-type="bibr"><sup>6</sup></xref>
<italic toggle="yes">tax</italic> mRNA expression correlated with HTLV‐I PVL in HAM/TSP patients at baseline and at month 6 of raltegravir treatment (Fig. <xref rid="acn351437-fig-0003" ref-type="fig">3C</xref>).</p>
                <fig position="float" fig-type="Figure" id="acn351437-fig-0003">
                  <label>Figure 3</label>
                  <caption>
                    <p>HTLV‐1 mRNA expression in PBMC of HAM/TSP patients with raltegravir. (A) Group analysis of <italic toggle="yes">tax</italic> mRNA expression in PBMCs of HAM/TSP patients after ex vivo culture for 20 h. Error bars represent standard deviation. (B) Group analysis of <italic toggle="yes">HBZ</italic> mRNA expression in PBMCs of HAM/TSP patients at pre‐culture. Error bars represent standard deviation. (C) Correlation of HTLV‐1 PVL in PBMC and HTLV‐1 <italic toggle="yes">tax</italic> mRNA expression in PBMC of HAM/TSP patients at baseline and at month 6 of raltegravir treatment. Closed circles and opened circles represent the data at baseline (<italic toggle="yes">R</italic> = 0.6168, <italic toggle="yes">P</italic> = 0.0109) and at month 6 of raltegravir treatment (<italic toggle="yes">R</italic> = 0.6206, <italic toggle="yes">P</italic> = 0.0103), respectively. (D) Percentage change in <italic toggle="yes">tax</italic> mRNA expression among the three HAM/TSP groups based on the percentage changes of HTLV‐1 PVL in the 6‐month treatment phase compared to the baseline. Error bars represent standard deviation. (E) Percentage change in <italic toggle="yes">HBZ</italic> mRNA expression among the three HAM/TSP groups based on the percentage changes of HTLV‐1 PVL in the 6‐month treatment phase compared to the baseline. Error bars represent standard deviation. (F) Group analysis of HTLV‐1 Tax protein expression in CD4<sup>+</sup>CD25<sup>+</sup> T cells of HAM/TSP patients after ex vivo PBMC culture for 20 h. Error bars represent standard deviation. (G) Group analysis of HTLV‐1 Tax and IFN‐γ expressions in CD4<sup>+</sup>CD25<sup>+</sup> T cells of HAM/TSP patients after ex vivo PBMC culture for 20 h. Error bars represent standard deviation.</p>
                  </caption>
                  <graphic xlink:href="ACN3-8-1970-g005" position="anchor" id="jats-graphic-5"/>
                </fig>
                <p>We also examined if there is any difference in <italic toggle="yes">tax</italic> and <italic toggle="yes">HBZ</italic> mRNA expression among the three HAM/TSP groups based on the percentage change of HTLV‐1 PVL in the 6‐month treatment phase compared to baseline. Interestingly, while there was no significant difference of the percentage change of <italic toggle="yes">tax</italic> mRNA expression in HAM/TSP patients (Fig. <xref rid="acn351437-fig-0003" ref-type="fig">3D</xref>), a downward trend in the percentage change of <italic toggle="yes">HBZ</italic> mRNA expression was observed in group 1 compared to group 2 or 3 (Fig. <xref rid="acn351437-fig-0003" ref-type="fig">3E</xref>). In addition to <italic toggle="yes">tax</italic> mRNA expression, we assessed Tax protein and IFN‐γ expression in CD4<sup>+</sup>CD25<sup>+</sup> T cells, a major reservoir of HTLV‐1, in ex vivo PBMC culture of HAM/TSP patients at baseline, at month 6, and month 15 of the trial. Tax expression was significantly decreased in CD4<sup>+</sup>CD25<sup>+</sup> T cells of HAM/TSP patients at month 15 compared to the baseline (Fig. <xref rid="acn351437-fig-0003" ref-type="fig">3F</xref>). Concomittant with this decrease in Tax protein expression, there was also a significant reduction of Tax‐induced IFN‐γ expression in CD4<sup>+</sup>CD25<sup>+</sup> T cells of HAM/TSP patients at month 15 compared to the baseline (Fig. <xref rid="acn351437-fig-0003" ref-type="fig">3G</xref>). These results demonstrated that raltegravir had a selective inhibitory effect on the expression of HTLV‐1 mRNA, especially <italic toggle="yes">tax</italic> mRNA, from PBMCs of HAM/TSP patients.</p>
              </sec>
              <sec id="acn351437-sec-0019">
                <title>Immunological changes in peripheral blood and CSF of HAM/TSP patients treated with raltegravir</title>
                <p>Several types of immune cell dysregulations in peripheral blood and CSF have been reported in HAM/TSP including increased activated T cells, effector T cells, and antibody secreting B cells.<xref rid="acn351437-bib-0027" ref-type="bibr"><sup>27</sup></xref> Some immunological markers of HAM/TSP patients at baseline and post‐treatment of raltegravir are summarized in Table <xref rid="acn351437-tbl-0003" ref-type="table">3</xref>. As shown in Figure <xref rid="acn351437-fig-0004" ref-type="fig">4A</xref>, as expected, a higher frequency of CD4<sup>+</sup>CD25<sup>+</sup> T cells was detected in both peripheral blood and CSF of HAM/TSP patients before raltegravir treatment compared to control ranges of blood and CSF of 27 healthy volunteers (25%–75% percentile) highlighted in gray (Fig. <xref rid="acn351437-fig-0004" ref-type="fig">4A</xref>). Importantly, group analysis demonstrated that the frequency of CD4<sup>+</sup>CD25<sup>+</sup> T cells significantly decreased in both peripheral blood and CSF of HAM/TSP patients after treatment with raltegravir, particularly at month 15 (Fig. <xref rid="acn351437-fig-0004" ref-type="fig">4A</xref>). It has been reported that antibody secreting B cells are elevated in CSF of HAM/TSP patients and that this was significantly correlated with increased CD4<sup>+</sup>CD25<sup>+</sup> T cells in the CSF.<xref rid="acn351437-bib-0009" ref-type="bibr"><sup>9</sup></xref> In 15 HAM/TSP patients, antibody secreting B cells were detected in the CSF of HAM/TSP patient, except for one HAM/TSP patient (HAM #9), before treatment (mean 4.873 ± standard deviation 4.504; Table <xref rid="acn351437-tbl-0003" ref-type="table">3</xref>). Interestingly, after treatment with raltegravir, antibody secreting B cells gradually decreased in CSF of HAM/TSP patients and was sustained at the 15‐month time point (<italic toggle="yes">n</italic> = 15; Fig. <xref rid="acn351437-fig-0004" ref-type="fig">4B</xref>). Moreover, 10 HAM/TSP patients had no detectable antibody secreting B cells at month 6 and/or 15 (Table <xref rid="acn351437-tbl-0003" ref-type="table">3</xref>). The subset analysis of CSF B cells was not done in one HAM/TSP patient pre‐ and post‐raltegravir treatment due to low B‐cell number in the CSF (HAM#4; Table <xref rid="acn351437-tbl-0003" ref-type="table">3</xref>).</p>
                <fig position="float" fig-type="Figure" id="acn351437-fig-0004">
                  <label>Figure 4</label>
                  <caption>
                    <p>Immunological changes in peripheral blood and CSF of HAM/TSP patients with raltegravir. (A) Group analysis of frequencies of CD25<sup>+</sup> cells in blood and CSF CD4<sup>+</sup> T cells of HAM/TSP patients. (B) Group analysis of frequencies of antibody secreting B cells in CSF B cells of HAM/TSP patients. (C) Group analysis of frequencies of CD25<sup>+</sup> cells in blood and CSF CD8<sup>+</sup> T cells of HAM/TSP patients. (D) Group analysis of frequencies of CD122<sup>+</sup> cells in blood and CSF CD8<sup>+</sup> T cells of HAM/TSP patients. Error bars represent standard deviation. In (A), (C), (D), the control ranges of blood and CSF of 27 healthy volunteers (25%–75% percentile) are highlighted in gray.</p>
                  </caption>
                  <graphic xlink:href="ACN3-8-1970-g001" position="anchor" id="jats-graphic-7"/>
                </fig>
                <p>In addition, the frequency of CD8<sup>+</sup>CD25<sup>+</sup> T cells was also significantly decreased in peripheral blood of HAM/TSP patients although not in the CSF after treatment with raltegravir (Fig. <xref rid="acn351437-fig-0004" ref-type="fig">4C</xref>). Group analysis also demonstrated a decreased frequency in CD122(IL‐15 receptor β chain)<sup>+</sup> cells in both peripheral blood and CSF CD8<sup>+</sup> T cells of HAM/TSP patients after treatment with raltegravir (Fig. <xref rid="acn351437-fig-0004" ref-type="fig">4D</xref>). However, other biological markers of HAM/TSP patients including CD4/CD8 ratio, T‐cell subsets (effector/memory (CD45RA<sup>−</sup>CD27<sup>−</sup>) T cells, effector (CD45RA<sup>+</sup>CD27<sup>−</sup>) T cells, memory folicular helper (CD45RA<sup>−</sup>CXCR5<sup>+</sup>) CD4<sup>+</sup> T cells and FoxP3 expression), and NK cell subsets (CD56<sup>bright</sup> and CD56<sup>dim</sup>), did not show any significant changes during the trial (data not shown). In addition, there was no significant difference of these immunological markers among the three HAM/TSP groups based on the percentage change of HTLV‐1 PVL in the 6‐month treatment phase compared to baseline (data not shown). Collectively, these results demonstrated alterations in the immune profiles of HAM/TSP patients with raltegravir, most notably decreased activated T cells and antibody secreting B cells in peripheral blood and/or CSF.</p>
              </sec>
              <sec id="acn351437-sec-0020">
                <title>Spontaneous lymphoproliferation in HAM/TSP patients with raltegravir</title>
                <p>Spontaneous lymphoproliferation is a well‐established measure of ex vivo T‐cell activation for HTLV‐1‐infected subjects induced by several factors including increased IL‐2 and IL‐15 associated with HTLV‐1 gene expression.<xref rid="acn351437-bib-0028" ref-type="bibr"><sup>28</sup></xref>, <xref rid="acn351437-bib-0029" ref-type="bibr"><sup>29</sup></xref> Given the observed inhibitory effects in this trial of raltegravir on HTLV‐1 mRNA expression and activated T cells, we asked whether treatment with raltegravir would effect HTLV‐1‐associated spontaneous lymphoproliferation. As shown in Figure <xref rid="acn351437-fig-0005" ref-type="fig">5A</xref>, group analysis of the 16 HAM/TSP patients demonstrated a significant reduction in [<sup>3</sup>H]‐thymidine uptake by spontaneous proliferating PBMC compared to their baseline values at month 6 of raltegravir treatment that was maintained at month 15 of the trial (Fig. <xref rid="acn351437-fig-0005" ref-type="fig">5A</xref>). In addition, a CFSE assay was used to assess spontaneous proliferating PBMC.<xref rid="acn351437-bib-0023" ref-type="bibr"><sup>23</sup></xref> Figure <xref rid="acn351437-fig-0005" ref-type="fig">5B</xref> shows a representative dot plot of T‐cell proliferation in a HAM/TSP patient (HAM #14) cultured at day 4 using CFSE in which both CD4<sup>+</sup> and CD8<sup>+</sup> T cells can clearly be seen to proliferate at the pretreatment time point. At month 6 of raltegravir treatment (Fig. <xref rid="acn351437-fig-0005" ref-type="fig">5B</xref>), there was a reduction in proliferation of both CD4<sup>+</sup> and CD8<sup>+</sup> T cells. Group analysis demonstrated that spontaneous proliferation of CD4<sup>+</sup> T cells, as well as CD4<sup>+</sup>CD25<sup>+</sup> T cells, was significantly inhibited in cultured PBMC of HAM/TSP patients at month 6 of raltegravir treatment, although the reduction of CD8<sup>+</sup> T‐cell proliferation did not reach significance (Fig. <xref rid="acn351437-fig-0005" ref-type="fig">5C</xref>). By month 15, proliferation of CD4<sup>+</sup> and CD4<sup>+</sup>CD25<sup>+</sup> T cells were back to baseline. These CFSE results support the observation that treatment with raltegravir reduced HAM/TSP spontaneous proliferation particularly in activated CD4<sup>+</sup>CD25<sup>+</sup> T cells, suggesting that raltegravir might inhibit T‐cell activation through modulation of HTLV‐1 <italic toggle="yes">tax</italic> mRNA expression.</p>
                <fig position="float" fig-type="Figure" id="acn351437-fig-0005">
                  <label>Figure 5</label>
                  <caption>
                    <p>Spontaneous lymphoproliferation in HAM/TSP patients with raltegravir. (A) Group analysis of spontaneous lymphoproliferation in PBMCs of HAM/TSP patients at ex vivo culture of Day 4. Error bars represent standard deviation. (B) Representative dot plot of CFSE staining in CD4<sup>+</sup> and CD8<sup>+</sup> T cells of a HAM/TSP patient (HAM #14) after ex vivo culture of Day 4. (C) Group analysis of spontaneous CD4<sup>+</sup>, CD4<sup>+</sup>CD25<sup>+</sup>, and CD8<sup>+</sup> T cell proliferation in PBMCs of HAM/TSP patients at ex vivo culture of Day 4. Error bars represent standard deviation.</p>
                  </caption>
                  <graphic xlink:href="ACN3-8-1970-g002" position="anchor" id="jats-graphic-9"/>
                </fig>
              </sec>
            </sec>
            <sec sec-type="discussion" id="acn351437-sec-0021">
              <title>Discussion</title>
              <p>HAM/TSP is associated with high levels of HTLV‐1 PVL, most notably in the CSF that drive a variety of immune functions associated with the pathogenesis of this disorder.<xref rid="acn351437-bib-0030" ref-type="bibr"><sup>30</sup></xref> Therefore, reduction in HTLV‐1 PVL may help infected individuals by ameliorating such abnormal immune dysregulatory mechanisms and subsequent development of disease. Since it had been reported that raltegravir, a clinically approved integrase inhibitor, efficiently blocked cell‐to‐cell HTLV‐1 infection, integration, and immortalization in vitro,<xref rid="acn351437-bib-0011" ref-type="bibr"><sup>11</sup></xref>, <xref rid="acn351437-bib-0012" ref-type="bibr"><sup>12</sup></xref>, <xref rid="acn351437-bib-0013" ref-type="bibr"><sup>13</sup></xref> we assessed the effects of raltegravir in HAM/TSP patients in a 6‐month treatment phase, followed by a 9‐month post‐treatment phase, on HTLV‐1 PVL and the associated immune activation markers. Clinically, neurological scores and objective measurement remained stable in all patients during the 6‐month treatment phase, with some expected variability. There was no correlation of clinical change with HTLV‐1 PVL. No patients showed any significant related toxicity or manifested unusually progressive disease during the trial.</p>
              <p>Quantification of HTLV‐1 PVL is one of the best tools for confirmation and evaluation of disease development in HTLV‐1‐infected individuals, although HTLV‐1 PVL in PBMCs varies widely between individuals and remains relatively stable within individuals over time.<xref rid="acn351437-bib-0031" ref-type="bibr"><sup>31</sup></xref>, <xref rid="acn351437-bib-0032" ref-type="bibr"><sup>32</sup></xref> In our study, group analysis demonstrated no significant changes of HTLV‐1 PVL in either PBMCs or CSF cells of HAM/TSP patients during the trial. However, data from individual patients showed a differential reduction of HTLV‐1 PVL in a subset of patients after raltegravir treatment, even during the post‐treatment period, suggesting a potential low viral suppression effect of raltegravir on HTLV‐1 PVL in certain HAM/TSP patients. Consistent with a previous report that <italic toggle="yes">HBZ</italic> mRNA expression is correlated with HTLV‐1 PVL in HAM/TSP patients,<xref rid="acn351437-bib-0026" ref-type="bibr"><sup>26</sup></xref> the group of HAM/TSP patients that demonstrated a reduction of HTLV‐1 PVL (group 1) also showed a reduction in <italic toggle="yes">HBZ</italic> mRNA expression. This supports our results in which raltegravir reduced HTLV‐1 PVL in a subset of HAM/TSP patients (Fig. <xref rid="acn351437-fig-0002" ref-type="fig">2</xref>). Unexpectedly, measures of HTLV‐1 <italic toggle="yes">tax</italic> mRNA expression showed a significant reduction in PBMCs of HAM/TSP patients at month 6 of raltegravir treatment, which was sustained at month 15 of the trial. It is well known that <italic toggle="yes">tax</italic> mRNA and Tax protein is spontaneously expressed in a subset of HTLV‐1‐infected PBMCs of HTLV‐1‐infected individuals after short‐term ex vivo culture.<xref rid="acn351437-bib-0006" ref-type="bibr"><sup>6</sup></xref>, <xref rid="acn351437-bib-0033" ref-type="bibr"><sup>33</sup></xref> Recent high‐throughput analysis of genomic integration sites of HTLV‐1 determine the pattern of Tax expression of the provirus and the clonal abundance and pathogenic potential of infected T‐cell clones in vivo.<xref rid="acn351437-bib-0034" ref-type="bibr"><sup>34</sup></xref>, <xref rid="acn351437-bib-0035" ref-type="bibr"><sup>35</sup></xref> This analysis surprisingly revealed that there was no significant difference in HTLV‐1 clonality between HAM/TSP patients and ACs and that high HTLV‐1 PVL in HAM/TSP patients was correlated with a large number of distinct HTLV‐1‐infected T‐cell clones with unique insertion sites, and not with the extent of clonal proliferation of a few infected T‐cell clones in the host.<xref rid="acn351437-bib-0034" ref-type="bibr"><sup>34</sup></xref> In addition, the majority of spontaneous Tax‐expressing cells corresponded to a large number of distinct and less expanded viral clones, rather than a small number of clonally expanded viral clones in HAM/TSP patients.<xref rid="acn351437-bib-0035" ref-type="bibr"><sup>35</sup></xref> Therefore, our results suggest that inhibitory effect of raltegravir on <italic toggle="yes">tax</italic> mRNA expression may result in a reduction of less expanded viral clones in HAM/TSP patients leading to a reduction of HTLV‐1 PVL in a subset of HAM/TSP patients. While HTLV‐1 transmission occurs primarily via cell‐to‐cell contact such as formation of a virological synapse,<xref rid="acn351437-bib-0036" ref-type="bibr"><sup>36</sup></xref> it has been reported that HTLV‐1 LTR DNA circles, indicators of an active HTLV‐1 replication, are detected at low levels in PBMCs of symptomatic carriers and patients with ATLL and HAM/TSP, strongly suggesting that HTLV‐1 viral replication is maintained during infection.<xref rid="acn351437-bib-0037" ref-type="bibr"><sup>37</sup></xref> Since little is known about HTLV‐1 proviral latency including reactivation associated with new infection in HAM/TSP patients, further studies are needed to evaluate this mode of HTLV‐1 transmission and to determine if raltegravir can function to prevent integration of virus into uninfected cells in vivo.</p>
              <p>Our results demonstrated that while raltegravir did not dramatically reduce the HTLV‐1 PVL, it may instead modulate HTLV‐1 <italic toggle="yes">tax</italic> mRNA expression as well as the T‐cell activation that characterize HAM/TSP. In HIV‐1, raltegravir effectively prevents integration of HIV‐1 proviral DNA into the host cell genome, and clinical trials of raltegravir in HIV‐1‐infected adults showed significant decline of plasma HIV‐1 RNA levels and increase of CD4<sup>+</sup> T‐cell counts in the raltegravir‐treated group.<xref rid="acn351437-bib-0010" ref-type="bibr"><sup>10</sup></xref> In HAM/TSP patients, increased HTLV‐1 PVL, viral expression and T‐cell activation have been reported.<xref rid="acn351437-bib-0006" ref-type="bibr"><sup>6</sup></xref>, <xref rid="acn351437-bib-0007" ref-type="bibr"><sup>7</sup></xref>, <xref rid="acn351437-bib-0008" ref-type="bibr"><sup>8</sup></xref>, <xref rid="acn351437-bib-0009" ref-type="bibr"><sup>9</sup></xref> Specifically, CD4<sup>+</sup>CD25<sup>+</sup> T cells contain high levels of HTLV‐1 proviral DNA, highly express HTLV‐1 <italic toggle="yes">tax</italic> mRNA, and produce various cytokines including IFN‐γ.<xref rid="acn351437-bib-0007" ref-type="bibr"><sup>7</sup></xref>, <xref rid="acn351437-bib-0008" ref-type="bibr"><sup>8</sup></xref> HAM/TSP patients have higher frequencies of CD4<sup>+</sup>CD25<sup>+</sup> T cells in the CSF as well as in the peripheral blood compared to ACs and healthy controls, which also significantly correlated with increased HTLV‐1 PVL and dysregulation of the other immune cells, such as CD8<sup>+</sup> T cells and B cells in HAM/TSP.<xref rid="acn351437-bib-0009" ref-type="bibr"><sup>9</sup></xref>, <xref rid="acn351437-bib-0038" ref-type="bibr"><sup>38</sup></xref> During treatment with raltegravir, HAM/TSP patients showed a reduction of CD4<sup>+</sup>CD25<sup>+</sup> T cells in both peripheral blood and CSF that was sustained at month 15 of the trial. Downward trends in antibody secreting B cells and activated CD8<sup>+</sup> T cells in the CSF were also observed in raltegravir treated HAM/TSP patients. Importantly, <italic toggle="yes">tax</italic> mRNA, Tax protein, and Tax‐induced IFN‐γ expressions were decreased in ex vivo PBMC culture of HAM/TSP patients at month 15 compared to baseline. In addition, inhibition of spontaneous lymphoproliferation was detected in HAM/TSP patients during the 6‐month treatment with raltegravir and/or post‐treatment period. In ex vivo PBMC culture of HAM/TSP patients, increase in plus‐strand transcription of HTLV‐1 provirus, especially HTLV‐1 Tax gene products, induce various cellular genes including the NF‐κB and CREB/ATF pathway and the common γ chain family of cytokines such as IL‐2/IL‐2 receptor and IL‐15/IL‐15 receptor.<xref rid="acn351437-bib-0025" ref-type="bibr"><sup>25</sup></xref>, <xref rid="acn351437-bib-0039" ref-type="bibr"><sup>39</sup></xref> Increased expressions of critical immune mediators directly contribute to both CD4<sup>+</sup> and CD8<sup>+</sup> T‐cell activation and proliferation observed in HAM/TSP patients. Therefore, our findings suggest that a decrease in plus‐strand transcription associated with raltegravir treatment may modulate T‐cell activation and proliferation in HAM/TSP patients, but further studies would be required to determine how raltegravir affect these cell populations as well as virus infection in HAM/TSP patients during treatment phase and also at post‐treatment period.</p>
              <p>Collectively, the results in this relatively short‐term trial of raltegravir demonstrated marked reductions in spontaneous lymphoproliferation, a marker of T‐cell activation characteristic of HAM/TSP patients in all treated patients. While group statistics showed no significant inhibition of HTLV‐1 proviral load during the trial, subset analysis of individual patients demonstrated differential inhibition of HTLV‐1 PVL in some patients in either PBMC or CSF. There was no correlation of inhibition of CSF PVL with reduced PBMC PVL. Although this trial was not powered for clinical efficacy, raltegravir was well tolerated and no patient progressed during the 6‐month treatment period and 9‐month follow‐up. It is therefore reasonable to consider longer duration trials with raltegravir to determine if sustained clinical benefit including limiting progression of disease could be achieved. Since HTLV‐1 infection is associated with a variety of clinical manifestations with varying rates of progression,<xref rid="acn351437-bib-0040" ref-type="bibr"><sup>40</sup></xref> it is of interest to determine the effects of raltegravir in HAM/TSP patients with different courses of disease progression and in HTLV‐1‐infected individuals who may not yet have fully developed HAM/TSP. Moreover, future therapeutic studies including antiviral compounds combined with immunomodulatory therapies may be needed to maximize effective responses in patients with chronic virus‐associated neuroinflammatory disease such as HAM/TSP.</p>
            </sec>
            <sec id="acn351437-sec-0023">
              <title>Author Contributions</title>
              <p>BJB, SA, JD, RM, IC, and JO coordinated clinical work and patient care. YE‐A AV, NN, and SN performed the experimental works. YE‐A performed statistical analysis. YE‐A, BJB, and JO contributed to discussion and paper writing. SJ supervised the project and contributed to discussion and writing.</p>
            </sec>
            <sec sec-type="COI-statement" id="acn351437-sec-0024">
              <title>Conflict of Interest</title>
              <p>The authors have declared that no conflict of interest exists.</p>
            </sec>
          </body>
          <back>
            <ack id="acn351437-sec-0022">
              <title>Acknowledgments</title>
              <p>Anti‐Tax antibody (LT‐4) was kindly provided by Dr. Yuetsu Tanaka, University of the Ryukyus, Okinawa, Japan. This research was supported by the Intramural Research Program of the NINDS, NIH. The support of the NIH inpatient and outpatient neurology staff is acknowledged.</p>
            </ack>
            <ref-list content-type="cited-references" id="acn351437-bibl-0001">
              <title>References</title>
              <ref id="acn351437-bib-0001">
                <label>1</label>
                <mixed-citation publication-type="journal" id="acn351437-cit-0001"><string-name><surname>Gessain</surname><given-names>A</given-names></string-name>, <string-name><surname>Vernant</surname><given-names>JC</given-names></string-name>, <string-name><surname>Maurs</surname><given-names>L</given-names></string-name>, et al. <article-title>Antibodies to human T‐lymphotropic virus type‐I in patients with tropical spastic paraparesis</article-title>. <source>Lancet.</source>
<year>1985</year>;<volume>2</volume>(<issue>8452</issue>):<fpage>407</fpage>‐<lpage>470</lpage>.<pub-id pub-id-type="pmid">2863442</pub-id></mixed-citation>
              </ref>
              <ref id="acn351437-bib-0002">
                <label>2</label>
                <mixed-citation publication-type="journal" id="acn351437-cit-0002"><string-name><surname>Osame</surname><given-names>M</given-names></string-name>, <string-name><surname>Usuku</surname><given-names>K</given-names></string-name>, <string-name><surname>Izumo</surname><given-names>S</given-names></string-name>, et al. <article-title>HTLV‐I associated myelopathy, a new clinical entity</article-title>. <source>Lancet.</source>
<year>1986</year>;<volume>1</volume>(<issue>8488</issue>):<fpage>1031</fpage>‐<lpage>1032</lpage>.</mixed-citation>
              </ref>
              <ref id="acn351437-bib-0003">
                <label>3</label>
                <mixed-citation publication-type="journal" id="acn351437-cit-0003"><string-name><surname>Umehara</surname><given-names>F</given-names></string-name>, <string-name><surname>Izumo</surname><given-names>S</given-names></string-name>, <string-name><surname>Nakagawa</surname><given-names>M</given-names></string-name>, et al. <article-title>Immunocytochemical analysis of the cellular infiltrate in the spinal cord lesions in HTLV‐I‐associated myelopathy</article-title>. <source>J Neuropathol Exp Neurol.</source>
<year>1993</year>;<volume>52</volume>(<issue>4</issue>):<fpage>424</fpage>‐<lpage>430</lpage>.<pub-id pub-id-type="pmid">8355031</pub-id></mixed-citation>
              </ref>
              <ref id="acn351437-bib-0004">
                <label>4</label>
                <mixed-citation publication-type="journal" id="acn351437-cit-0004"><string-name><surname>Nagai</surname><given-names>M</given-names></string-name>, <string-name><surname>Yamano</surname><given-names>Y</given-names></string-name>, <string-name><surname>Brennan</surname><given-names>MB</given-names></string-name>, <string-name><surname>Mora</surname><given-names>CA</given-names></string-name>, <string-name><surname>Jacobson</surname><given-names>S</given-names></string-name>. <article-title>Increased HTLV‐I proviral load and preferential expansion of HTLV‐I Tax‐specific CD8+ T cells in cerebrospinal fluid from patients with HAM/TSP</article-title>. <source>Ann Neurol.</source><year>2001</year>;<volume>50</volume>(<issue>6</issue>):<fpage>807</fpage>‐<lpage>812</lpage>.<pub-id pub-id-type="pmid">11761481</pub-id></mixed-citation>
              </ref>
              <ref id="acn351437-bib-0005">
                <label>5</label>
                <mixed-citation publication-type="journal" id="acn351437-cit-0005"><string-name><surname>Nagai</surname><given-names>M</given-names></string-name>, <string-name><surname>Usuku</surname><given-names>K</given-names></string-name>, <string-name><surname>Matsumoto</surname><given-names>W</given-names></string-name>, et al. <article-title>Analysis of HTLV‐I proviral load in 202 HAM/TSP patients and 243 asymptomatic HTLV‐I carriers: high proviral load strongly predisposes to HAM/TSP</article-title>. <source>J Neurovirol.</source>
<year>1998</year>;<volume>4</volume>(<issue>6</issue>):<fpage>586</fpage>‐<lpage>593</lpage>.<pub-id pub-id-type="pmid">10065900</pub-id></mixed-citation>
              </ref>
              <ref id="acn351437-bib-0006">
                <label>6</label>
                <mixed-citation publication-type="journal" id="acn351437-cit-0006"><string-name><surname>Yamano</surname><given-names>Y</given-names></string-name>, <string-name><surname>Nagai</surname><given-names>M</given-names></string-name>, <string-name><surname>Brennan</surname><given-names>M</given-names></string-name>, et al. <article-title>Correlation of human T‐cell lymphotropic virus type 1 (HTLV‐1) mRNA with proviral DNA load, virus‐specific CD8(+) T cells, and disease severity in HTLV‐1‐associated myelopathy (HAM/TSP)</article-title>. <source>Blood.</source>
<year>2002</year>;<volume>99</volume>(<issue>1</issue>):<fpage>88</fpage>‐<lpage>94</lpage>.<pub-id pub-id-type="pmid">11756157</pub-id></mixed-citation>
              </ref>
              <ref id="acn351437-bib-0007">
                <label>7</label>
                <mixed-citation publication-type="journal" id="acn351437-cit-0007"><string-name><surname>Yamano</surname><given-names>Y</given-names></string-name>, <string-name><surname>Araya</surname><given-names>N</given-names></string-name>, <string-name><surname>Sato</surname><given-names>T</given-names></string-name>, et al. <article-title>Abnormally high levels of virus‐infected IFN‐gamma+ CCR4+ CD4+ CD25+ T cells in a retrovirus‐associated neuroinflammatory disorder</article-title>. <source>PLoS One.</source>
<year>2009</year>;<volume>4</volume>(<issue>8</issue>):<elocation-id>e6517</elocation-id>.<pub-id pub-id-type="pmid">19654865</pub-id></mixed-citation>
              </ref>
              <ref id="acn351437-bib-0008">
                <label>8</label>
                <mixed-citation publication-type="journal" id="acn351437-cit-0008"><string-name><surname>Yamano</surname><given-names>Y</given-names></string-name>, <string-name><surname>Takenouchi</surname><given-names>N</given-names></string-name>, <string-name><surname>Li</surname><given-names>H‐C</given-names></string-name>, et al. <article-title>Virus‐induced dysfunction of CD4+CD25+ T cells in patients with HTLV‐I‐associated neuroimmunological disease</article-title>. <source>J Clin Invest.</source>
<year>2005</year>;<volume>115</volume>(<issue>5</issue>):<fpage>1361</fpage>‐<lpage>1368</lpage>.<pub-id pub-id-type="pmid">15864353</pub-id></mixed-citation>
              </ref>
              <ref id="acn351437-bib-0009">
                <label>9</label>
                <mixed-citation publication-type="journal" id="acn351437-cit-0009"><string-name><surname>Enose‐Akahata</surname><given-names>Y</given-names></string-name>, <string-name><surname>Azodi</surname><given-names>S</given-names></string-name>, <string-name><surname>Smith</surname><given-names>BR</given-names></string-name>, et al. <article-title>Immunophenotypic characterization of CSF B cells in virus‐associated neuroinflammatory diseases</article-title>. <source>PLoS Pathog</source>. <year>2018</year>;<volume>14</volume>(<issue>4</issue>):<elocation-id>e1007042</elocation-id>.<pub-id pub-id-type="pmid">29709026</pub-id></mixed-citation>
              </ref>
              <ref id="acn351437-bib-0010">
                <label>10</label>
                <mixed-citation publication-type="journal" id="acn351437-cit-0010"><string-name><surname>Brooks</surname><given-names>KM</given-names></string-name>, <string-name><surname>Sherman</surname><given-names>EM</given-names></string-name>, <string-name><surname>Egelund</surname><given-names>EF</given-names></string-name>, et al. <article-title>Integrase inhibitors: after 10 years of experience, is the best yet to come?</article-title>
<source>Pharmacotherapy</source>. <year>2019</year>;<volume>39</volume>(<issue>5</issue>):<fpage>576</fpage>‐<lpage>598</lpage>.<pub-id pub-id-type="pmid">30860610</pub-id></mixed-citation>
              </ref>
              <ref id="acn351437-bib-0011">
                <label>11</label>
                <mixed-citation publication-type="journal" id="acn351437-cit-0011"><string-name><surname>Seegulam</surname><given-names>ME</given-names></string-name>, <string-name><surname>Ratner</surname><given-names>L</given-names></string-name>. <article-title>Integrase inhibitors effective against human T‐cell leukemia virus type 1</article-title>. <source>Antimicrob Agents Chemother.</source><year>2011</year>;<volume>55</volume>:<fpage>2011</fpage>‐<lpage>2017</lpage>.<pub-id pub-id-type="pmid">21343468</pub-id></mixed-citation>
              </ref>
              <ref id="acn351437-bib-0012">
                <label>12</label>
                <mixed-citation publication-type="journal" id="acn351437-cit-0012"><string-name><surname>Barski</surname><given-names>MS</given-names></string-name>, <string-name><surname>Minnell</surname><given-names>JJ</given-names></string-name>, <string-name><surname>Maertens</surname><given-names>GN</given-names></string-name>. <article-title>Inhibition of HTLV‐1 infection by HIV‐1 first‐ and second‐generation integrase strand transfer inhibitors</article-title>. <source>Front Microbiol.</source><year>2019</year>;<volume>10</volume>:<elocation-id>1877</elocation-id>.<pub-id pub-id-type="pmid">31474960</pub-id></mixed-citation>
              </ref>
              <ref id="acn351437-bib-0013">
                <label>13</label>
                <mixed-citation publication-type="journal" id="acn351437-cit-0013"><string-name><surname>Trevino</surname><given-names>A</given-names></string-name>, <string-name><surname>Parra</surname><given-names>P</given-names></string-name>, <string-name><surname>Bar‐Magen</surname><given-names>T</given-names></string-name>, <string-name><surname>Garrido</surname><given-names>C</given-names></string-name>, <string-name><surname>de Mendoza</surname><given-names>C</given-names></string-name>, <string-name><surname>Soriano</surname><given-names>V</given-names></string-name>. <article-title>Antiviral effect of raltegravir on HTLV‐1 carriers</article-title>. <source>J Antimicrob Chemother.</source><year>2012</year>;<volume>67</volume>(<issue>1</issue>):<fpage>218</fpage>‐<lpage>221</lpage>.<pub-id pub-id-type="pmid">21965433</pub-id></mixed-citation>
              </ref>
              <ref id="acn351437-bib-0014">
                <label>14</label>
                <mixed-citation publication-type="journal" id="acn351437-cit-0014"><string-name><surname>Kurtzke</surname><given-names>JF</given-names></string-name>. <article-title>Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS)</article-title>. <source>Neurology</source>. <year>1983</year>;<volume>33</volume>(<issue>11</issue>):<fpage>1444</fpage>‐<lpage>1452</lpage>.<pub-id pub-id-type="pmid">6685237</pub-id></mixed-citation>
              </ref>
              <ref id="acn351437-bib-0015">
                <label>15</label>
                <mixed-citation publication-type="journal" id="acn351437-cit-0015"><string-name><surname>Sipe</surname><given-names>JC</given-names></string-name>, <string-name><surname>Knobler</surname><given-names>RL</given-names></string-name>, <string-name><surname>Braheny</surname><given-names>SL</given-names></string-name>, <string-name><surname>Rice</surname><given-names>GP</given-names></string-name>, <string-name><surname>Panitch</surname><given-names>HS</given-names></string-name>, <string-name><surname>Oldstone</surname><given-names>MB</given-names></string-name>. <article-title>A neurologic rating scale (NRS) for use in multiple sclerosis</article-title>. <source>Neurology.</source><year>1984</year>;<volume>34</volume>(<issue>10</issue>):<fpage>1368</fpage>‐<lpage>1372</lpage>.<pub-id pub-id-type="pmid">6541311</pub-id></mixed-citation>
              </ref>
              <ref id="acn351437-bib-0016">
                <label>16</label>
                <mixed-citation publication-type="journal" id="acn351437-cit-0016"><string-name><surname>Kaufman</surname><given-names>M</given-names></string-name>, <string-name><surname>Moyer</surname><given-names>D</given-names></string-name>, <string-name><surname>Norton</surname><given-names>J</given-names></string-name>. <article-title>The significant change for the Timed 25‐foot Walk in the multiple sclerosis functional composite</article-title>. <source>Mult Scler.</source><year>2000</year>;<volume>6</volume>(<issue>4</issue>):<fpage>286</fpage>‐<lpage>290</lpage>.<pub-id pub-id-type="pmid">10962550</pub-id></mixed-citation>
              </ref>
              <ref id="acn351437-bib-0017">
                <label>17</label>
                <mixed-citation publication-type="journal" id="acn351437-cit-0017"><string-name><surname>Schmidt</surname><given-names>F</given-names></string-name>, <string-name><surname>Oliveira</surname><given-names>AL</given-names></string-name>, <string-name><surname>Araujo</surname><given-names>A</given-names></string-name>. <article-title>Development and validation of a neurological disability scale for patients with HTLV‐1 associated myelopathy/tropical spastic paraparesis (HAM/TSP): the IPEC‐1 scale</article-title>. <source>Neurology</source>. <year>2012</year>;<volume>78</volume>(<issue>supplement 1</issue>):<fpage>P03258</fpage>.</mixed-citation>
              </ref>
              <ref id="acn351437-bib-0018">
                <label>18</label>
                <mixed-citation publication-type="journal" id="acn351437-cit-0018"><string-name><surname>Hauser</surname><given-names>SL</given-names></string-name>, <string-name><surname>Dawson</surname><given-names>DM</given-names></string-name>, <string-name><surname>Lehrich</surname><given-names>JR</given-names></string-name>, et al. <article-title>Intensive immunosuppression in progressive multiple sclerosis. A randomized, three‐arm study of high‐dose intravenous cyclophosphamide, plasma exchange, and ACTH</article-title>. <source>N Engl J Med</source>. <year>1983</year>;<volume>308</volume>(<issue>4</issue>):<fpage>173</fpage>‐<lpage>180</lpage>.<pub-id pub-id-type="pmid">6294517</pub-id></mixed-citation>
              </ref>
              <ref id="acn351437-bib-0019">
                <label>19</label>
                <mixed-citation publication-type="journal" id="acn351437-cit-0019"><string-name><surname>Goodkin</surname><given-names>DE</given-names></string-name>, <string-name><surname>Hertsgaard</surname><given-names>D</given-names></string-name>, <string-name><surname>Seminary</surname><given-names>J</given-names></string-name>. <article-title>Upper extremity function in multiple sclerosis: improving assessment sensitivity with box‐and‐block and nine‐hole peg tests</article-title>. <source>Arch Phys Med Rehabil.</source><year>1988</year>;<volume>69</volume>(<issue>10</issue>):<fpage>850</fpage>‐<lpage>854</lpage>.<pub-id pub-id-type="pmid">3178453</pub-id></mixed-citation>
              </ref>
              <ref id="acn351437-bib-0020">
                <label>20</label>
                <mixed-citation publication-type="journal" id="acn351437-cit-0020"><string-name><surname>Brunetto</surname><given-names>GS</given-names></string-name>, <string-name><surname>Massoud</surname><given-names>R</given-names></string-name>, <string-name><surname>Leibovitch</surname><given-names>EC</given-names></string-name>, et al. <article-title>Digital droplet PCR (ddPCR) for the precise quantification of human T‐lymphotropic virus 1 proviral loads in peripheral blood and cerebrospinal fluid of HAM/TSP patients and identification of viral mutations</article-title>. <source>J Neurovirol.</source>
<year>2014</year>;<volume>20</volume>(<issue>4</issue>):<fpage>341</fpage>‐<lpage>351</lpage>.<pub-id pub-id-type="pmid">24781526</pub-id></mixed-citation>
              </ref>
              <ref id="acn351437-bib-0021">
                <label>21</label>
                <mixed-citation publication-type="journal" id="acn351437-cit-0021"><string-name><surname>Enose‐Akahata</surname><given-names>Y</given-names></string-name>, <string-name><surname>Ngouth</surname><given-names>N</given-names></string-name>, <string-name><surname>Ohayon</surname><given-names>J</given-names></string-name>, et al. <article-title>Effect of teriflunomide on cells from patients with human T‐cell lymphotropic virus type 1‐associated neurologic disease</article-title>. <source>Neurol Neuroimmunol Neuroinflamm.</source>
<year>2021</year>;<volume>8</volume>(<issue>3</issue>):<fpage>e986</fpage>.<pub-id pub-id-type="pmid">33837058</pub-id></mixed-citation>
              </ref>
              <ref id="acn351437-bib-0022">
                <label>22</label>
                <mixed-citation publication-type="journal" id="acn351437-cit-0022"><string-name><surname>Oh</surname><given-names>U</given-names></string-name>, <string-name><surname>Yamano</surname><given-names>Y</given-names></string-name>, <string-name><surname>Mora</surname><given-names>CA</given-names></string-name>, et al. <article-title>Interferon‐beta1a therapy in human T‐lymphotropic virus type I‐associated neurologic disease</article-title>. <source>Ann Neurol</source>. <year>2005</year>;<volume>57</volume>(<issue>4</issue>):<fpage>526</fpage>‐<lpage>534</lpage>.<pub-id pub-id-type="pmid">15786444</pub-id></mixed-citation>
              </ref>
              <ref id="acn351437-bib-0023">
                <label>23</label>
                <mixed-citation publication-type="journal" id="acn351437-cit-0023"><string-name><surname>Enose‐Akahata</surname><given-names>Y</given-names></string-name>, <string-name><surname>Abrams</surname><given-names>A</given-names></string-name>, <string-name><surname>Massoud</surname><given-names>R</given-names></string-name>, et al. <article-title>Humoral immune response to HTLV‐1 basic leucine zipper factor (HBZ) in HTLV‐1‐infected individuals</article-title>. <source>Retrovirology.</source>
<year>2013</year>;<volume>10</volume>:<fpage>19</fpage>.<pub-id pub-id-type="pmid">23405908</pub-id></mixed-citation>
              </ref>
              <ref id="acn351437-bib-0024">
                <label>24</label>
                <mixed-citation publication-type="journal" id="acn351437-cit-0024"><string-name><surname>Enose‐Akahata</surname><given-names>Y</given-names></string-name>, <string-name><surname>Vellucci</surname><given-names>A</given-names></string-name>, <string-name><surname>Jacobson</surname><given-names>S</given-names></string-name>. <article-title>Role of HTLV‐1 Tax and HBZ in the pathogenesis of HAM/TSP</article-title>. <source>Front Microbiol</source>. <year>2017</year>;<volume>8</volume>:<fpage>2563</fpage>.<pub-id pub-id-type="pmid">29312243</pub-id></mixed-citation>
              </ref>
              <ref id="acn351437-bib-0025">
                <label>25</label>
                <mixed-citation publication-type="journal" id="acn351437-cit-0025"><string-name><surname>Matsuoka</surname><given-names>M</given-names></string-name>, <string-name><surname>Jeang</surname><given-names>KT</given-names></string-name>. <article-title>Human T‐cell leukaemia virus type 1 (HTLV‐1) infectivity and cellular transformation</article-title>. <source>Nat Rev Cancer</source>. <year>2007</year>;<volume>7</volume>(<issue>4</issue>):<fpage>270</fpage>‐<lpage>280</lpage>.<pub-id pub-id-type="pmid">17384582</pub-id></mixed-citation>
              </ref>
              <ref id="acn351437-bib-0026">
                <label>26</label>
                <mixed-citation publication-type="journal" id="acn351437-cit-0026"><string-name><surname>Saito</surname><given-names>M</given-names></string-name>, <string-name><surname>Matsuzaki</surname><given-names>T</given-names></string-name>, <string-name><surname>Satou</surname><given-names>Y</given-names></string-name>, et al. <article-title>In vivo expression of the HBZ gene of HTLV‐1 correlates with proviral load, inflammatory markers and disease severity in HTLV‐1 associated myelopathy/tropical spastic paraparesis (HAM/TSP)</article-title>. <source>Retrovirology.</source>
<year>2009</year>;<volume>6</volume>:<fpage>19</fpage>.<pub-id pub-id-type="pmid">19228429</pub-id></mixed-citation>
              </ref>
              <ref id="acn351437-bib-0027">
                <label>27</label>
                <mixed-citation publication-type="journal" id="acn351437-cit-0027"><string-name><surname>Enose‐Akahata</surname><given-names>Y</given-names></string-name>, <string-name><surname>Jacobson</surname><given-names>S</given-names></string-name>. <article-title>Immunovirological markers in HTLV‐1‐associated myelopathy/tropical spastic paraparesis (HAM/TSP)</article-title>. <source>Retrovirology.</source><year>2019</year>;<volume>16</volume>(<issue>1</issue>):<fpage>35</fpage>.<pub-id pub-id-type="pmid">31783764</pub-id></mixed-citation>
              </ref>
              <ref id="acn351437-bib-0028">
                <label>28</label>
                <mixed-citation publication-type="journal" id="acn351437-cit-0028"><string-name><surname>Azimi</surname><given-names>N</given-names></string-name>, <string-name><surname>Jacobson</surname><given-names>S</given-names></string-name>, <string-name><surname>Leist</surname><given-names>T</given-names></string-name>, <string-name><surname>Waldmann</surname><given-names>TA</given-names></string-name>. <article-title>Involvement of IL‐15 in the pathogenesis of human T lymphotropic virus type I‐associated myelopathy/tropical spastic paraparesis: implications for therapy with a monoclonal antibody directed to the IL‐2/15R beta receptor</article-title>. <source>J Immunol</source>. <year>1999</year>;<volume>163</volume>(<issue>7</issue>):<fpage>4064</fpage>‐<lpage>4072</lpage>.<pub-id pub-id-type="pmid">10491011</pub-id></mixed-citation>
              </ref>
              <ref id="acn351437-bib-0029">
                <label>29</label>
                <mixed-citation publication-type="journal" id="acn351437-cit-0029"><string-name><surname>Itoyama</surname><given-names>Y</given-names></string-name>, <string-name><surname>Minato</surname><given-names>S</given-names></string-name>, <string-name><surname>Kira</surname><given-names>J</given-names></string-name>, et al. <article-title>Spontaneous proliferation of peripheral blood lymphocytes increased in patients with HTLV‐I‐associated myelopathy</article-title>. <source>Neurology</source>. <year>1988</year>;<volume>38</volume>(<issue>8</issue>):<fpage>1302</fpage>‐<lpage>1307</lpage>.<pub-id pub-id-type="pmid">2899862</pub-id></mixed-citation>
              </ref>
              <ref id="acn351437-bib-0030">
                <label>30</label>
                <mixed-citation publication-type="journal" id="acn351437-cit-0030"><string-name><surname>Bangham</surname><given-names>CR</given-names></string-name>, <string-name><surname>Araujo</surname><given-names>A</given-names></string-name>, <string-name><surname>Yamano</surname><given-names>Y</given-names></string-name>, <string-name><surname>Taylor</surname><given-names>GP</given-names></string-name>. <article-title>HTLV‐1‐associated myelopathy/tropical spastic paraparesis</article-title>. <source>Nat Rev Dis Primers.</source><year>2015</year>;<volume>1</volume>:<elocation-id>15012</elocation-id>.<pub-id pub-id-type="pmid">27188208</pub-id></mixed-citation>
              </ref>
              <ref id="acn351437-bib-0031">
                <label>31</label>
                <mixed-citation publication-type="journal" id="acn351437-cit-0031"><string-name><surname>Matsuzaki</surname><given-names>T</given-names></string-name>, <string-name><surname>Nakagawa</surname><given-names>M</given-names></string-name>, <string-name><surname>Nagai</surname><given-names>M</given-names></string-name>, et al. <article-title>HTLV‐I proviral load correlates with progression of motor disability in HAM/TSP: analysis of 239 HAM/TSP patients including 64 patients followed up for 10 years</article-title>. <source>J Neurovirol</source>. <year>2001</year>;<volume>7</volume>(<issue>3</issue>):<fpage>228</fpage>‐<lpage>234</lpage>.<pub-id pub-id-type="pmid">11517397</pub-id></mixed-citation>
              </ref>
              <ref id="acn351437-bib-0032">
                <label>32</label>
                <mixed-citation publication-type="journal" id="acn351437-cit-0032"><string-name><surname>Demontis</surname><given-names>MA</given-names></string-name>, <string-name><surname>Hilburn</surname><given-names>S</given-names></string-name>, <string-name><surname>Taylor</surname><given-names>GP</given-names></string-name>. <article-title>Human T cell lymphotropic virus type 1 viral load variability and long‐term trends in asymptomatic carriers and in patients with human T cell lymphotropic virus type 1‐related diseases</article-title>. <source>AIDS Res Hum Retroviruses</source>. <year>2013</year>;<volume>29</volume>(<issue>2</issue>):<fpage>359</fpage>‐<lpage>364</lpage>.<pub-id pub-id-type="pmid">22894552</pub-id></mixed-citation>
              </ref>
              <ref id="acn351437-bib-0033">
                <label>33</label>
                <mixed-citation publication-type="journal" id="acn351437-cit-0033"><string-name><surname>Hanon</surname><given-names>E</given-names></string-name>, <string-name><surname>Hall</surname><given-names>S</given-names></string-name>, <string-name><surname>Taylor</surname><given-names>GP</given-names></string-name>, et al. <article-title>Abundant tax protein expression in CD4+ T cells infected with human T‐cell lymphotropic virus type I (HTLV‐I) is prevented by cytotoxic T lymphocytes</article-title>. <source>Blood</source>. <year>2000</year>;<volume>95</volume>(<issue>4</issue>):<fpage>1386</fpage>‐<lpage>1392</lpage>.<pub-id pub-id-type="pmid">10666215</pub-id></mixed-citation>
              </ref>
              <ref id="acn351437-bib-0034">
                <label>34</label>
                <mixed-citation publication-type="journal" id="acn351437-cit-0034"><string-name><surname>Gillet</surname><given-names>NA</given-names></string-name>, <string-name><surname>Malani</surname><given-names>N</given-names></string-name>, <string-name><surname>Melamed</surname><given-names>A</given-names></string-name>, et al. <article-title>The host genomic environment of the provirus determines the abundance of HTLV‐1‐infected T‐cell clones</article-title>. <source>Blood</source>. <year>2011</year>;<volume>117</volume>(<issue>11</issue>):<fpage>3113</fpage>‐<lpage>3122</lpage>.<pub-id pub-id-type="pmid">21228324</pub-id></mixed-citation>
              </ref>
              <ref id="acn351437-bib-0035">
                <label>35</label>
                <mixed-citation publication-type="journal" id="acn351437-cit-0035"><string-name><surname>Melamed</surname><given-names>A</given-names></string-name>, <string-name><surname>Laydon</surname><given-names>DJ</given-names></string-name>, <string-name><surname>Gillet</surname><given-names>NA</given-names></string-name>, <string-name><surname>Tanaka</surname><given-names>Y</given-names></string-name>, <string-name><surname>Taylor</surname><given-names>GP</given-names></string-name>, <string-name><surname>Bangham</surname><given-names>CR</given-names></string-name>. <article-title>Genome‐wide determinants of proviral targeting, clonal abundance and expression in natural HTLV‐1 infection</article-title>. <source>PLoS Pathog.</source><year>2013</year>;<volume>9</volume>(<issue>3</issue>):<elocation-id>e1003271</elocation-id>.<pub-id pub-id-type="pmid">23555266</pub-id></mixed-citation>
              </ref>
              <ref id="acn351437-bib-0036">
                <label>36</label>
                <mixed-citation publication-type="journal" id="acn351437-cit-0036"><string-name><surname>Gross</surname><given-names>C</given-names></string-name>, <string-name><surname>Thoma‐Kress</surname><given-names>AK</given-names></string-name>. <article-title>Molecular mechanisms of HTLV‐1 cell‐to‐cell transmission</article-title>. <source>Viruses</source>. <year>2016</year>;<volume>8</volume>(<issue>3</issue>):<fpage>74</fpage>.<pub-id pub-id-type="pmid">27005656</pub-id></mixed-citation>
              </ref>
              <ref id="acn351437-bib-0037">
                <label>37</label>
                <mixed-citation publication-type="journal" id="acn351437-cit-0037"><string-name><surname>Fox</surname><given-names>J</given-names></string-name>, <string-name><surname>Hilburn</surname><given-names>S</given-names></string-name>, <string-name><surname>Demontis</surname><given-names>M‐A</given-names></string-name>, et al. <article-title>Long terminal repeat circular DNA as markers of active viral replication of human T lymphotropic virus‐1 in vivo</article-title>. <source>Viruses</source>. <year>2016</year>;<volume>8</volume>(<issue>3</issue>):<fpage>80</fpage>.<pub-id pub-id-type="pmid">26985903</pub-id></mixed-citation>
              </ref>
              <ref id="acn351437-bib-0038">
                <label>38</label>
                <mixed-citation publication-type="journal" id="acn351437-cit-0038"><string-name><surname>Yamano</surname><given-names>Y</given-names></string-name>, <string-name><surname>Cohen</surname><given-names>CJ</given-names></string-name>, <string-name><surname>Takenouchi</surname><given-names>N</given-names></string-name>, et al. <article-title>Increased expression of human T lymphocyte virus type I (HTLV‐I) Tax11‐19 peptide‐human histocompatibility leukocyte antigen A*201 complexes on CD4+ CD25+ T Cells detected by peptide‐specific, major histocompatibility complex‐restricted antibodies in patients with HTLV‐I‐associated neurologic disease</article-title>. <source>J Exp Med</source>. <year>2004</year>;<volume>199</volume>(<issue>10</issue>):<fpage>1367</fpage>‐<lpage>1377</lpage>.<pub-id pub-id-type="pmid">15136590</pub-id></mixed-citation>
              </ref>
              <ref id="acn351437-bib-0039">
                <label>39</label>
                <mixed-citation publication-type="journal" id="acn351437-cit-0039"><string-name><surname>Waldmann</surname><given-names>TA</given-names></string-name>. <article-title>The shared and contrasting roles of IL2 and IL15 in the life and death of normal and neoplastic lymphocytes: implications for cancer therapy</article-title>. <source>Cancer Immunol Res</source>. <year>2015</year>;<volume>3</volume>(<issue>3</issue>):<fpage>219</fpage>‐<lpage>227</lpage>.<pub-id pub-id-type="pmid">25736261</pub-id></mixed-citation>
              </ref>
              <ref id="acn351437-bib-0040">
                <label>40</label>
                <mixed-citation publication-type="journal" id="acn351437-cit-0040"><string-name><surname>Yamano</surname><given-names>Y</given-names></string-name>, <string-name><surname>Sato</surname><given-names>T</given-names></string-name>. <article-title>Clinical pathophysiology of human T‐lymphotropic virus‐type 1‐associated myelopathy/tropical spastic paraparesis</article-title>. <source>Front Microbiol</source>. <year>2012</year>;<volume>3</volume>:<fpage>389</fpage>.<pub-id pub-id-type="pmid">23162542</pub-id></mixed-citation>
              </ref>
            </ref-list>
          </back>
        </article>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
